claudia.stefanutti@uniroma1.it's picture

Benvenuti! 

 

Sede: Policlinico Umberto I, Edificio I Clinica Medica, III Piano Montacarichi - Citofono

 

Attività assistenziale primaria: Tecniche Terapeutiche Extracorporee

Course Code Year Course - Attendance Bulletin board
MEDICINA INTERNA E CHIRURGIA GENERALE III 1056172 2022/2023
MEDICINA INTERNA E CHIRURGIA GENERALE III 10596615 2022/2023
MEDICINA INTERNA E CHIRURGIA GENERALE III 10596615 2021/2022
MEDICINA INTERNA E CHIRURGIA GENERALE III 1026309 2021/2022
MEDICINA INTERNA E CHIRURGIA GENERALE III 1026309 2020/2021
MEDICINA INTERNA E CHIRURGIA GENERALE III 10596615 2020/2021
MEDICINA INTERNA E CHIRURGIA GENERALE III 1026309 2019/2020
METODOLOGIA MEDICO SCIENTIFICA PRE-CLINICA 1056190 2019/2020
ANATOMIA UMANA 1026645 2019/2020
MEDICINA INTERNA E CHIRURGIA GENERALE III 1026309 2018/2019
ANATOMIA UMANA 1026645 2018/2019
METODOLOGIA MEDICO SCIENTIFICA PRE-CLINICA 1056190 2018/2019
DIAGNOSTICA VASCOLARE 1052073 2017/2018
ANATOMIA UMANA 1026645 2017/2018
METODOLOGIA MEDICO SCIENTIFICA DI BASE 1026636 2017/2018
MEDICINA INTERNA E CHIRURGIA GENERALE III 1026309 2017/2018
MEDICINA INTERNA E CHIRURGIA GENERALE III 1026309 2016/2017
ANATOMIA UMANA 1026645 2016/2017

Martedì 10.30-12.30
Giovedì 10.30-12.30

Claudia STEFANUTTI Curriculum Vitae

Place: Rome, Italy
Date: May 2022

Part I General Information

Full Name Claudia STEFANUTTI
Date of Birth December 9, 1957
Place of Birth Mogadiscio (Somalia) (EE)
Citizenship Italian
Permanent Address 18, Via 8 Ottobre Alesso TRASAGHIS (UD) 33010
Mobile Phone Number 0039 335308807 3473609298 (06) 49970578
E-mail claudia.stefanutti@uniroma1.it
Spoken Languages English Turkish French (Elementary) Japanese (Elementary) learned on site

Part II Education

Type Year Institution Notes (Degree, Experience, )
University graduation 1982 Sapienza University of Rome Medicine and Surgery
110/110 cum Laude
Post-graduate studies 1987 - 1989 Sapienza University of Rome - Department of Hematology
Department of Emergency Surgery Investigating innovative extracorporeal techniques (Selective Therapeutic Techniques).
During her training in surgery she introduced for the first time, the autologous blood recovery from wound or surgical site.
PhD 1988 University of Siena Experimental Medicine: Atherosclerosis (1st Cycle) Appointed first in selection
Specialty 1986 Sapienza University of Rome Liver and Metabolic Diseases
Specialty 1994 Sapienza University of Rome Emergency Surgery
CNR National Competition 1987 Italian National Research Council (Boll. Uff. CNR n . 6 del 22/10/86) Data banks for molecular biology. Human Genome. Elegible
Licensure 01 1986 Ordine provinciale di Roma dei Medici Chirurghi e degli Odontoiatri M37342

Part III Appointments

IIIA Academic Appointments

Start End Institution Position
1991 2001 Sapienza University of Rome Graduate Technician (VII)
Umberto I Hospital
2001 Sapienza University of Rome Researcher (RTI)
2016 2026 National Scientific Qualification ASN Associate Professor
2019 2029 National Scientific Qualification ASN Full Professor

IIIB Other Appointments

Start End Institution Position
2017 2017 University of Ni , Serbia Visiting Professor
2018 2019 Medical University of Vienna, Austria Visiting Professor
2019 http://www.expertscape.com/ex/hyperlipidemias Recognized as an Expertscape World Expert in Hyperlipidemias (2019)
2017 2017 Publons Top Reviewer for 2017
2018 2018 Elsevier Reviewer Acknowledgement 2018

Part IV Teaching experience (Italy and abroad)

Corso di Laurea Specialistica C in Medicina e Chirurgia
Corso di Laurea Specialistica E in Medicina e Chirurgia
Corso di perfezionamento in Fisiopatologia, Diagnosi e Terapia delle Iperlipoproteinemie
Corso di perfezionamento in Alimentazione in Età Pediatrica
Corso di perfezionamento in Terapia dell Obesità e degli altri Stati di Malnutrizione
Corso di Diploma di Specializzazione in Gastroenterologia (III)
(Università degli Studi di Roma La Sapienza )
Corso di Diploma Universitario in Scienze Infermieristiche
(Università Pontina,Latina)
Corso di Perfezionamento in Plasmaferesi Terapeutica
(Università Cattolica del Sacro Cuore, Roma)
Master II livello in Aferesi Terapeutica Selettiva
Dottorato di Ricerca in Reumatologia Clinica e Sperimentale
Master II Livello in Tecniche Medico Ingegneristiche nel trattamento delle Insufficienze Multiorgano Integrate

Year Institution Lecture/Course
2016-2017 University of Ni , Serbia; as Visiting Professor April 5th2017 University lecture: Advances in the Diagnosis and Treatment of Genetic Dyslipidemias in Children
2018-2019 Medical University of Vienna, Austria; as Visiting Professor Student and postgraduate courses held:
November 19th2018; Special Dyslipidaemias due to inborn errors of lipid Metabolism;
December 10th2018; Treatment of Special Dyslipidaemias. Pharmacological and non-pharmacological approaches. Is there room for combination therapy?
January 14th2019; Is clinical lipidology an interdisciplinary deal?
January15th2019; University lecture: Lipoprotein(a) and Lipoprotein Apheresis Today
2020 University of Manchester PhD Student External Examiner
Doctoral Academy Thesis Support Team
Faculty of Biology, Medicine and Health

List of Conferences Role: Invited Speaker, Chair, Scientific Organizer

1992-2016 The attachment reports the certificates confirming the list of Conferences where the candidate had the role of Speaker, Chair or both. Several events where under the organisational and scientific responsibility of the applicant. The events / conferences are listed in chronological order in the attached scan showing the confirmation claims / leaflets.
2016-2020 As above. Conferences update (attached).

(Presenza in boards scientifici internazionali)

Part V - Society memberberships, Awards and Honors

2010 Full Member Elected of the International Society of Cytokines
2011 European Board Trustee of the International Society for Apheresis (ISFA).
2006-2012 Italian Multicenter Study on LDL-apheresis Working Group. National Coordinator
2013 Multidisciplinary International Group for Hemapheresis Therapy and Metabolic Disturbances Contrast Italy / Acronym: MIGHTY MEDIC International Coordinator
2009 Italian Society of Internal Medicine
2013 Gruppo di Studio delle Malattie Dismetaboliche e dell Aterosclerosi
2015 Full Member of the European Atherosclerosis Society
2015/2016 President of the Multidisciplinary International Group for Hemapheresis TherapY and MEtabolic DIsturbances Contrast (MIGHTY MEDIC) Global Scientific Society
2016 Invited Full Member of European Association for Research on Obesity in Childhood (EAROC)
2017/2019 Full Member of the Association for Preventive Pediatrics Serbia
2017 Full Member of Familial Chylomicronemia Syndrome (FCS)Task Force
2018 Advisory Board EMEA - KANEKA Corp. Osaka, Japan
2018 Full Member of the Società Italiana Ricerca Traslazionale e Professioni Sanitarie, S.I.R.T.E.P.S.
2018 Full Member of the Steering Committee of the International Lipid Expert Panel (ILEP)
2019 Full Member of the International Society of Preventive Pediatrics
2019 Full Member of the Executive Committee for the Regional Federation for Europe of the International Atherosclerosis Society (IAS)
Sept 2020 Invited Expert by International Atherosclerosis Society (IAS) FH Panel for International Integrated Guidance Document on FH

Member / Advisor

2012 New York LDL- Apheresis Study Steering Committee Meeting - Project Code
28005 Regeneron, USA. Advisory Board
2012 Combined Lomitapide and LDL-apheresis Treatment in Homozygous Familial Hypercholesterolemic Subjects Study Project - Aegerion, USA - Advisory Board
2012 Genzyme Global Advisory Board 5-6 December, Budapest, Hungary - Advisory Board
2013 Treatment of Symptomatic HyperLp(a)lipoproteinemia with Lipoprotein-apheresis.The Italian reality Osaka, Japan, May 15 2013 Advisory Board
2013 PACE Roundtable - Exploring the clinical benefits of MTP inhibition in HoFH Amsterdam (Holland) September 2, 2013 - Advisory Board
2014 Expert Working Group on Apheresis, Paris, 4th November 2014 - Aegerion Pharmaceuticals Advisory Board
2015 FH CTA consortium The consortium consists of 30 participants, mainly physicians treating large numbers of FH patients, from 16 countries -
2013-2016 European Research Collaboration Agreement between Sapienza University of Rome, Dept. of Molecular Medicine and Fresenius Medical Care Germany Deutschland GMBH. Scientific
Advisor and Research Consultant
2017 Full Member and Speaker of Familial Chylomicronemia Syndrome (FCS) Task Force
2018 Advisory Board EMEA - KANEKA Corp. Osaka, Japan

International Scientific, Research, and Editorial Collaboration:

1983 16th Ten Day International Teaching Seminar on Cardiovascular Epidemiology and Prevention. International Society and Federation of Cardiology, Susono (Japan).
1995 Scientific collaboration: Department of Cardiology and Artificial Organs. Koga Hospital. Kurume. Japan.
1996 By invitation of Dr. Josè Miguel Boquinhas, Director of Internal Medicine and Nephrology Departments of Santa Cruz Hospital and Dr. Egidio Pedro, Institute of Cardiology and Biochemistry Department, University of Lisbon (Portugal), to coordinate the development of the first Center for LDL-apheresis in Portugal, and as advisor for medical personnel training.
2000-2001 Scientific collaboration with Professor Thomas Bosch, Department of Nephrology, University of Meunchen, Germany, Grosshadern Hospital devoted to the development of a new method for low-dose citrate anticoagulation DALI LDL-apheresis , co-validated in Meunchen and Rome.
2002-2002 Subsequent scientific collaborations: Pediatric Endocrinology and Diabetology. Hôpital des Enfants. University of Geneva. Switzerland. 2003 New children's day centre. Hammersmith Hospital. London. Great Britain. Inherited Metabolic Disorders Clinical. Birmingham Children s Hospital. Great Britain.
2009 University of Pennsylvania, Department of Medicine. Professor Marina Cuchel Philadelphia U.S.A., A Phase III, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Lomitapide (AEGR-733) plus Current Maximal Tolerated Therapy (MTT) in Subjects with Severe Refractory Heterozygous Familial Hypercholesterolemia . 2010 Scientific advisor for LDL-apheresis; Griffith University School of Medicine Southport, Queensland (Australia), Professor Ian Hamilton-Craig (Internal Medicine and Preventive Cardiology) on Familial Hypercholesterolemia: a Model Care for Australia . 2011-2012 Scientific and editorial collaboration with Prof. Ulrich Julius. University "Carl Gustav Carus" of Dresden. Dresden, Germany.
2013 Dr Wolfgang Ramlow - Baltic Apheresis Working Groups Eco4Life Rostock, Germany. 2013 Prof. JJP Kastelein, Head of Department of Vascular Medicine Academic Medical Center - University of Amsterdam The Netherlands. 2013 Dr. Mariko Harada-Shiba, Director Department of Molecular Innovation in Lipidology - National Cerebral and Cardiovascular Center Research Institute, Osaka,Japan.
2013 Dr. Handrean Soran, Central Manchester University Hospitals NHS Foundation Trust 2013 Prof. Patrick Moriarty, Department of Internal Medicine, University of Kansas Medical
Center, Kansas City, U.S.A.
2014 Scientific and editorial collaboration with Prof. Thompson Gilbert R. Clinical Lipidology, Hammersmith Hospital, Imperial College London, Ducane Road, London W12 0NN, UK
2014 Prof. Eric Sijbrands, Head of Erasmus Cardiovascular Genetics Department - Erasmus MC, Rotterdam, The Netherlands
2015-2019 Prof. Kurt Widhalm, Clinical Nutrition and Head of Department of Nutrition and Metabolism at the University of Vienna (Austria)
2018-2019 Prof. Thomas Stulnig, Medical University of Vienna; Department of Medicine III - Clinical Division of Endocrinology and Metabolism 2015-2019 Prof. Watts Gerald F Royal Perth Hospital, School of Medicine and Pharmacology, The University of Western Australia.
2017-2019 Prof. Bjelakovic Bojko, Clinic of Pediatrics, Clinical Center Nis Medical Faculty, University of Nis, Serbia.
2018-2019 Prof. Maciej Banach, Head of Cardiovascular Research Centre at University of Zielona Gora, full Professor of Cardiology at the Medical University of Lodz (MUL) and PMMHRI and Head of Department of Hypertension at the MUL, Lodz, Poland.
2018-2019 Prof Michal Vrablik Associate Professor of Internal Medicine at the 1st Faculty of Medicine, Charles University in Prague, the Czech Republic.

Peer reviewer

Cochrane Renal Group. Peer Reviewer
HEART UK The Cholesterol Charity Peer Reviewer
National Science Centre (Narodowe Centrum Nauki - NCN; http://www.ncn.gov.pl). Poland Peer Reviewer
Italian National Association for Familial Hypercholesterolaemia (A.N.I.F.) Scientific Committee National Coordinator
Osservatorio Malattie Rare - www.osservatoriomalattierare.it - Scientific Committee Member
For the evaluation of research products in the framework of the Italian Evaluation of Research Quality exercise (VQR 2004-2010) National Agency for the Evaluation of Universities and Research Institutes Peer Reviewer
University of Sassari - Banco di Sardegna Foundation Regione Sardegna Peer Reviewer
REPRISE Register of Expert Peer Reviewers for Italian Scientific Evaluation -European Research Council (ERC) Peer Reviewer
Publons: Top Reviewer 2017
Elsevier Reviewer Acknowledgement 2018

Editorial Board Member / Peer Reviewer of the following Journals:

Journal of Biomedical Research, BMC Gastroenterology, Journal of Pharmacology & Clinical Toxicology, Clinical and Research in Hepatology and Gastroenterology, Expert Opinion on Pharmacotherapy, Medicinal Chemistry, Pediatrics, Dove Medical Press Journals, Therapeutic Apheresis and Dialysis, Recent Patents on Endocrine Metabolic & Immune Drug Discovery Lipids, Artificial Organs, Cytokine, Thyroid: official journal of the American Thyroid Association, European Heart Journal, JOP: Journal of the pancreas, Journal of Clinical Apheresis, Current Medicinal Chemistry, European Journal of Internal Medicine, New England Journal of Medicine, Saudi Medical Journal, Medical Principles and Practice, Journal of Membrane and Separation Technology, Journal of Crohn's and Colitis, World Journal of Gastroenterology, Express Submission and Peer-review System (ESPS), QJM: An International Journal of Medicine, Nutrients, Case Reports in Critical Care, BMJ Case reports. PLOS One, Case Reports in Neurological Medicine, Atherosclerosis, Journal of Clinical Lipidology, Angiology

(Attrazione di finanziamenti competitivi nazionali e internazionali)

Part VI - Funding Information [grants as PI-principal investigator or I-investigator]

- 1983-1986 Progetto Finalizzato Medicina Preventiva e Riabilitativa (CNR): Special project
- 1986 Ministero della Sanità (MS): Research Project on Menopause- related Metabolic Disturbances
- 1991-1995 Progetto Finalizzato Prevenzione e Controllo dei Fattori di Malattia (CNR). Special project
- 1989-1991 Multicenter trial on the efficacy and safety of dextrane sulfate cellulose Low-Density Lipoprotein -apheresis in patients affected by homozygous familial hypercholesterolemia.
- 1996 Progetto Finalizzato Prevenzione e Controllo dei Fattori di Malattia (CNR). Special project
- 1996 Clinical Trial: FACT Study Fluvastatin Alone and in Combination Treatment N. LES-I-05 Sandoz.
- 1998 C1q Immunoadsorption: cellular immune reaction in patients with immune complex-mediated diseases. Code C1q-P. Open Feasibility Study. Fresenius AG, St. Wendel,Germany.
- 1999-2000 Research project: DALI low-dose citrate LDL-apheresis: evaluation of a new hemoperfusional plasmapheresis system (ART). Fresenius AG, St. Wendel, Germany.
- 2000-2001 Clinical Trial: Multicenter randomized double blind-placebo study on cerivastatin (0.4 mg/d) vs simvastatin (20 mg/d) in patients with Primary hypercholesterolemia. BAY w 6228/IMPACT Trial N. 10156. Bayer.
- 2002-2003 Clinical Trial: A multicenter, double-blind, placebo-controlled study to evaluate the safety and efficacy of MK-0767 monotherapy in patients with type 2 diabetes mellitus. Merck & Co. Inc. U.S.A.
- 2006-2008 Italian Multicenter Study (IMS) on LDL-apheresis (LDLa) Working Group. B.Braun
- Avitum Italy, Caridian-BCT Europe, Fresenius Medical Care Germany, Fresenius Medical Care, Italia
- 2009 The 2009 2nd Italian Consensus Conference on LDL-apheresis. Kaneka Pharma Europe
- 2009-2010 Clinical Trial: A Phase III, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Lomitapide (AEGR-733) plus Current Maximal Tolerated Therapy (MTT) in Subjects with Severe Refractory Heterozygous Familial Hypercholesterolemia .
- 2010-2011 Cytokines Profile in Serum of Homozygous Familial Hypercholesterolaemia is changed by
LDL-apheresis - Kaneka Pharma Europe N.V. (Japan)
- 2011 Apheresis-inducible cytokines pattern change in severe, genetic dyslipidemias. Fresenius
Medical Care (Germany)
- 2011 Clinical trial: "Modifying Orphan Disease Evaluation (MODE) Study: A multicenter, open-label study of the
effects of CER-001 on plaque volume in subjects with Homozygous
Familial Hypercholesterolemia
(HoFH) . Cerenis Therapeutics, S.A.
- 2012 Clinical trial: A 52-Week Open-Label Extension and Safety Study of Pitavastatin in High-Risk Hyperlipidaemia in Childhood . Kowa Research Europe Ltd
- 2012 Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients with Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol . Genzyme Corporation
2013-2016 COLLABORATION AGREEMENT BETWEEN Sapienza University of Rome, Centro di Spesa, Department of Molecular Medicine, P.le Aldo Moro, 5, Rome, Tax code 80209930587, Director, Professor Angela Santoni and Professor Claudia Stefanutti as scientific responsible, and the Organisation/Company FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH, registered offices Else-Kröner-Straße 1, 61352 Bad Homburg v.d.H, Tax Code DE812033564.
2014 Phase 3 severe hypertriglyceridemia study (CS5) and phase 3 Familial Chylomicronemia Syndrome (FCS) study (CS6) both evaluating the efficacy of a subcutaneous investigational drug as compared to placebo on the change in fasting triglycerides (TG) from baseline. Ionis, USA. National Coordinator
2015 A Randomized, Actively Controlled, Open-label, Multicenter Study of Efficacy and Safety of Evolocumab Compared With Low Density Lipoprotein Cholesterol (LDL-C) Apheresis, Followed by Single-Arm Evolocumab Administration in Subjects Receiving LDL-C Apheresis Prior to Study Enrolment. Amgen, Inc, USA. National Coordinator
- 2016-2017 R727-CL-1628 HoFH Study in Participants 12 years of age with Homozygous Familial Hypercholesterolemia (HoFH)
- 2018- 2019 R1500-CL-1719 HoFH - Evaluate the Long-Term Safety and Efficacy of Evinacumab in Patients with Homozygous Familial Hypercholesterolemia (HoFH)
- 2017-2019 Clinical Trial based on Protocol No. FHGT002 AA V8-mediated Low Density Lipoprotein Receptor (LDLR) Gene Replacement in Subjects with Homozygous Familial Hypercholesterolaemia
-

Part VII Research Activities

Keywords Brief Description
Medical device -Extracorporeal Therapeutic Techniques Lipid metabolism disorders including rare diseases; Immunological disorders; Atherosclerosis; Preventive cardiology
Extracorporeal Therapeutic Techniques; Clinical trials (Lipid-lowering drugs and Medical devices Investigation/Upgrade)
Lipid and lipoprotein disorders
Immunological disorders (autoimmune diseases)
Atherosclerosis
Preventive cardiology

Part VIII Summary of Scientific Achievements

Updated to November 13, 2020 and acknowledged by web-based archives and scientific database

SCOPUS

1_ Publications: 125
2_ Hirsch index: 25
3_ Total citations: 2397
4_Mean citations per publication: 19.176

ISI Web of Knowledge

1_ Publications: 130
2_ Hirsch index: 24
3_ Total citations: 2047
4_ Mean citations per publication: 16.1

Normalized H index* (Scopus) 0.65 ^
Normalized H index* (ISI Web) 0.63 ^

*H index divided by the academic seniority. ^ underestimating the real productivity as the author was editorially active well before the advent of Internet and any web-based electronic database (see the general list of publications reported below)

Numero massimo di pubblicazioni (n.12) selezionabili per la valutazione di merito nell ambito della propria intera produzione scientifica:

Impact factor» totale e «impact factor» medio per pubblicazione, calcolati in relazione all anno della pubblicazione (banca dati di riferimento: Journal Citation Report ® Clarivate Analytics, 2018):

Impact factor totale: 168.259

Impact factor medio per pubblicazione in relazione all anno della pubblicazione:
riportato accanto ad ogni pubblicazione indicizzata: 14.02158

Pubblicazioni relative agli ultimi 5 anni, a partire dal 1° gennaio del quinto anno anteriore all anno di pubblicazione del bando

Impact factor» totale e «impact factor» medio per pubblicazione, calcolati in relazione all anno della pubblicazione (banca dati di riferimento: Journal Citation Report ® Clarivate Analytics, 2018):

Impact factor totale: 275.604

Impact factor medio per pubblicazione in relazione all anno della pubblicazione:
riportato accanto ad ogni pubblicazione indicizzata: 5.742

(Riconoscibilità internazionale della produzione scientifica complessiva)

Part IX Selected Publications

List of the publications selected for the evaluation. For each publication report title, authors, reference data, journal IF (if applicable), citations, press/media release (if any).

A_ Book Chapters

- Claudia Stefanutti, Claudia Morozzi: Low Density Lipoprotein Apheresis. 04/2013: pages 12; , ISBN: 978-1-62257-701-9
- Stefanutti, Vivenzio, Mazzarella: Lipoprotein And Hemocoagulatory Parameters During Therapeutic Plasmapheresis In Homozygous And Heterozygous Familial Hypercholesterolemia. 01/1993: pages 223-233; , ISBN: 3805558430
- Stefanutti, Perrone, Galoppi: Long-Term Effect On Plasma-Lipid And Lipoprotein Profile Of Transdermal And Oral Replacement Therapy In Postmenopausal Women. 01/1992: pages 365-368;
- Stefanutti, Di Giacomo, Vivenzio: Gemfibrozil Alone And Combined With Cholestyramine In The Treatment Of Primary Hyperlipoproteinemia. 01/1992: pages 583-586;
- Stefanutti, Mazzarella, Vivenzio: Extracorporeal Atherogenic Lipoprotein Removal In Patients With Homozygous Familial Hypercholesterolemia. 01/1992: pages 333-344;
- Angelico, Capocaccia, Stefanutti C, GREPCO: The Grepco Studies - Methodology, Prevalence and Incidence Data. 01/1991: pages 12: 3-6;
- Angelico, Capocaccia, Stefanutti C, GREPCO: Serum-Lipids And Gallstone Disease. 01/1991: pages 12: 121-127;
- Attili, Capri, Repice, Stefanutti C: The Natural-History of Gallstones - The Grepco Experience. 01/1991: pages 12: 47-50;
- Stefanutti, Isacchi, GC, Mazzarella: Variables Involved In The Treatment Of Severe Hyperlipoproteinemias By Combined Drug and LDL-Apheresis Treatment. 01/1990: pages 498-505;
- Stefanutti, Isacchi, GC, Masci: Dextran Sulfate Cellulose LDL-Affinity Apheresis In The Treatment Of Severe Familial Hypercholesterolemia And Nonfamilial Hyperlipoproteinemia - A Clinical Report On 12 Cases. 01/1990: pages 253-267;
- Bucci, Azzarri, Stefanutti C: Smoking-Habits and Risk of Asymptomatic Carotid Lesions in a Free-Living Population-Sample. 01/1990: pages 954: 337-342;
- Bucci, Antonini, Azzarri, Stefanutti C: Atherosclerotic Carotid Lesions in a Sample of Free Living Population - B-Mode Evaluation of Prevalence and Incidence. 01/1989: pages 817: 633-636;
- Claudia Stefanutti, Urbinati G.C., Perrone G., Mancone M., Pacioni F., Tesseri E., Zichella L., Ricci G: Serum lipid profiles in women using three different oral contraceptives: a different atherogenic risk?. 01/1987: pages 1095-1101;
- Claudia Stefanutti, Bucci A., Lalloni L., Chiaromonte C, Scarno A., Ricci P., Azzarri L., Ricci G: B-mode echography: a new approach to the Epidemiology of Atherosclerotic Disease?. 01/1986: pages 529-534;
- Claudia Stefanutti, Calvieri A, Fazio S., Fanelli V.: Effects of the diet supplementation with glucomannan fibers on type IIa e IIb monogenic and polygenic hypercolesterolemia: a clinical study. 01/1986: pages 793-798;
- Claudia Stefanutti, Bucci A., Lalloni L.: Clinica e diagnostica delle iperlipoproteinemie. 01/1986: pages 113-117;
- Claudia Stefanutti, Fazio S., Arca M., Angelico F., Calvieri A., Pacioni F, Fanelli V: Bezafibrate in the treatment of primary hyperlipidemias (HLP): further evaluation. 01/1986: pages 847-851;
- Claudia Stefanutti, GREPCO: Decreased serum high-density-lipoprotein cholesterol and risk of cholelithiasis. 01/1982: pages 39-43;

B_The (general) list of publications report original articles, proceedings and abstracts before the advent of Web and after the introduction of electronic Database on Web.

001 Stefanutti C. & Angelico F. (1982):
Coincidence of gallbladder disease and coronary heart disease: critical review of the literature.
Epatologia, 28 (6), 155, 365-376.

002 Stefanutti C. and the Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO) (1982):
Decreased serum high-density-lipoprotein cholesterol and risk of cholelithiasis. In: Atherosclerosis: etiopathogenesis, clinical evaluation and therapy.
Lenzi S. and Descovich G.C. eds. Editrice Compositori, Bologna, 39-43.

003 Angelico F, Arca M, Buongiorno A, Calvieri A, Monini P, Morisi G, Ricci G. and Stefanutti C. (1982):
Serum high density lipoprotein cholesterol in an Italian adult population sample: correlation with the main coronary risk factors.
Clinica & Terapia Cardiovascolare, 1 (3), 187-192.

004 Stefanutti C. and the Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO) (1982):
Factors influencing fasting serum bile acid levels in health. In: Bile acids and cholesterol in health and disease. Proceedings of VII International Bile Acid Meeting. Basel, October 12-14. Abstract, n. 94.

005 Stefanutti C. and the Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO) (1982):
Prevalence of gallstone disease in an adult female population in Rome. In: Bile acids and cholesterol in health and disease.
Proceedings of VII International Bile Acid Meeting.
Basel, October 12-14. Abstract, n. 151.

006 Stefanutti C. and the Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO) (1982):
Atherogenic serum lipid profile in gallstone subjects. In: Bile acids and cholesterol in health and disease. Proceedings of VII International Bile Acid Meeting. Basel, October 12-14. Abstract, p. 141.

007 Stefanutti C, Montali A, Guccione P, Cocca S, De Santis A, Marin M. (1982) :
Fattori di rischio coronarico e colelitiasi. Osservazioni nell ambito di una ricerca epidemiologica sulla colelitiasi: programma GREPCO.
Atti della III Riunione Scientifica del Gruppo Italiano per la Epidemiologia e la Prevenzione delle Malattie Cardiovascolari e Degenerative (GIEP). Hotel Hilton, Roma, 16 Dicembre. Abstract.

008 Calvieri A, Monini P, De Santis A, Arca M, Stefanutti C, Alvaro D. (1982):
Progamma GREPCO: prevalenza della colelitiasi in una popolazione lavorativa femminile. Atti della III Riunione Scientifica delle Malattie Cardiovascolari e Degenerative (GIEP). Hotel Hilton, Roma, 16 Dicembre. Abstract.

009 Stefanutti C. & Angelico F. (1983):
Asymptomatic cholelithiasis: myth or reality? Natural evolution, medical therapy and prophilactic colecystectomy.
Epatologia, 29 (2), 157, 63-72. 1 st Part.
Epatologia, 29 (3), 158, 121-133. 2 nd Part.

010 Montali A, Stefanutti C, Fazio S, Ciocca S, Arca M. (1983):
Is there an association between diet and cholelithiasis? Effect of nutritional factors and dietary behaviour on bile lithogenicity.
Epatologia, 29 (6), 161, 253-282.

011 Capocaccia L, Attili AF, Angelico M, Alvaro D, Ricci G, Angelico F, Stefanutti C. ed il Gruppo per la Epidemiologia e la Prevenzione della Colelitiasi (GREPCO) (1983):
Colelitiasi asintomatica: rilevanza clinica e programma di controllo.
Il Fegato, suppl. 29, 61-67.

012 Stefanutti C. e Gruppo Romano per la Epidemiologia e Prevenzione della Colelitiasi (GREPCO) (1983):
Prevalenza della colelitiasi in una popolazione lavorativa femminile e studio dei fattori associati legati al sesso.
Congresso Nazionale della Società Italiana di Gastroenterologia.
Bari, Italia, 30 giugno. Abstract.

013 Montali A, Angelico F, Arca M, Calvieri A, Del Monaco E, Di Berardo F, Fabiani L, Fazio S, Ricci G, Sibilia L, Stefanutti C, Urbinati GC, Andreatta S, Pannozzo F, Mangullo A. (1984):
Sovrappeso corporeo e pressione arteriosa in un campione di bambini in età scolare.
Clin. Dietol., 11 (2), 239.

014 Angelico F, Arca M, Calvieri A, Del Monaco E, Di Berardo F, Fabiani L, Fazio S, Montali A, Ricci G, Sibilia L, Stefanutti C, Urbinati GC, Andreatta S, Pannozzo F, Mangullo A. (1984):
Blood pressure in school children: study design, and preliminary results of a school, and community- based intervention programme. In: Proceedings of the International Symposium on Diet and Primary Prevention of Hypertension. Kuopio, Finland, June 25-27. Abstract, p. 4.

015 Stefanutti C. and the Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO) (1984):
Prevalence of gallstone disease in an Italian adult female population. Am. J. Epidemiol., 119 (5), 796-805. IF:4.933

016 Stefanutti C. and the Rome Group for the Epidemioloy and Prevention of Cholelithiasis (GREPCO) (1984):
Prevalence of gallstone disease in a rural adult female population.
J. Hepatol., suppl. 1 (1985), 58. Abstract, p. 115.

017 Angelico F, Arca M, Calvieri A, Del Monaco E, Di Berardo F, Fabiani L, Fazio S, Montali A, Ricci G, Sibilia L, Stefanutti C, Urbinati GC, Andreatta S, Pannozzo F, Mangullo A. (1984): A primary prevention programme of hypertension in children.
CVD Epidemiol. Newsletter, 36. Abstract, p. 108.

018 Stefanutti C. and the Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO) (1984):
Prevalence of gallstone disease three years after the end of a six-years multifactor primary prevention trial of coronary heart disease.
CVD Epidemiol. Newsletter, 36. Abstract, p. 109.

019 Bucci A, Conti R, Lalloni L, Scarno AG, Stefanutti C. and Ricci G. (1984):
The Rome Project of Coronary Heart Disease Prevention (PPCC): B-scan detection of atherosclerotic lesion. A subsample population study.
CVD Epidemiol. Newsletter, 36. Abstract, p. 116.

020 Bucci A, Lalloni L, Menotti A, Scarno AG, Stefanutti C, Ricci P, Urbinati GC and Ricci G. (1984):
The Sezze Project: prevalence of atherosclerotic lesion in a population sample. B.-scan detection and relationship with the main vascular risk factors.
CVD Epidemiol. Newsletter, 36. Abstract, p. 116-117.

021 Stefanutti C. and the Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO) (1984):
Prevalence of gallstone disease after a six-years multifactor primary prevention trial of coronary heart disease.
It. J. Gastroenterol., 16 (4). Abstract, p. 320.

022 Stefanutti C. and the Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO) (1984):
Validation of a statistical approach to clinical prediction of gallstone. Associazione Italiana per lo Studio del Fegato. Roma, 7-8 giugno. Abstract, p. 72.

023 Stefanutti C. and the Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO) (1984):
Composition of the dietary habits in gallstone females.
Associazione Italiana per lo Studio del Fegato. Roma, 7-8 giugno, Abstract, p. 73.

024 Stefanutti C. e il Gruppo di lavoro del G.I.E.P. (Gruppo Italiano per l Epidemiologia e la Prevenzione delle Malattie Cardiovascolari e Degenerative) e dell Obiettivo 43, Fattori di Rischio dell Arteriosclerosi, Progetto Finalizzato di Medicina Preventiva e Riabilitativa del Consiglio Nazionale delle Ricerche (1984):
Prevenzione primaria della cardiopatia coronarica in Italia.
Rapporto Rimini 84. Giorn. Arterioscl., 9: 249-256.

025 Ricci G, Stefanutti C. and the Rome Group for the Epidemiology and the Prevention of Cholelithiasis (GREPCO) (1984):
The GREPCO research progammes: aims and prevalence data.
In: Epidemiology and Prevention of Cholelithiasis, Capocaccia L., Ricci G., Angelico F., et al. eds, MTP Press, Lancaster, Boston, 9-14.

026 Angelico M, Stefanutti C. and the Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO) (1984):
Relationship between serum lipids and cholelithiasis. In: Epidemiology and Prevention of Cholelithiasis, Capocaccia L, Ricci G, Angelico F, et al. eds, MTP Press, Lancaster, Boston, 77-84.

027 Lalloni L, Stefanutti C. and the Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO) (1984):
Gallbladder ultrasonography as a diagnostic tool in epidemiological screenings. In: Epidemiology and Prevention of Cholelithiasis, Capocaccia L, Ricci G, Angelico F, et al. eds, MTP Press, Lancaster, Boston, 111-115.

028 Capocaccia L, Stefanutti C. and the Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO) (1984):
Clinical symptoms and gallstone disease, lessons from a population study. In: Epidemiology and Prevention of Cholelithiasis, Capocaccia L, Ricci G, Angelico F, et al. eds, MTP Press, Lancaster, Boston, 153-157.

029 Attili AF, Stefanutti C. and the Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO) (1984):
Dietary habits and cholelithiasis. In: Epidemiology and Prevention of Cholelithiasis, Capocaccia L, Ricci G, Angelico F, et al. eds, MTP Press, Lancaster, Boston, 175-181.

030 Angelico F, Stefanutti C. and the Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO) (1984):
Factors associated with gallstone disease: observations in the GREPCO study. In: Epidemiology and Prevention of Cholelithiasis, Capocaccia L, Ricci G, Angelico F, et al. eds, MTP Press, Lancaster, Boston, 185-192.

031 Urbinati GC, Stefanutti C. and the Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO) (1984):
Prevention of coronary heart disease and risk of cholelithiasis.
In: Epidemiology and Prevention of Cholelithiasis, Capocaccia L, Ricci G, Angelico F, et al. eds, MTP Press, Lancaster, Boston, 193-198.

032 Capocaccia L, Stefanutti C. and the Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO) (1984):
Logistic regression analysis in epidemiological research.
In: Epidemiology and Prevention of Cholelithiasis, Capocaccia L, Ricci G, Angelico F, et al. eds, MTP Press, Lancaster, Boston, 223-231.

033 Capocaccia L, Ricci G, Stefanutti C. and the Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO) (1985): Epidemiology of gallstone disease.
Ital. J. Gastoenterol., 17 (4), 215-218.

034 Stefanutti C, e the Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO) (1984):
Prevalence of cholelithiasis in a female population and study of risk factors sex-related.
Ital J Gastroenterol., 16, 61-84.

035 Capocaccia L, Stefanutti C. and the Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO) (1984):
Epidemiology of gallstone disease. In: Enterohepatic Circulation of Bile Acids and Sterol Metabolism. Paumgartner G, Stiehl A, Gerok W, eds, MTP Press Limited, Lancaster, Boston, 267-273.

036 Stefanutti C. and the Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO) (1984):
Relationship between hyperlipidaemia and gallstone disease: observations in an epidemiological survey. In: Liver and Lipid Metabolism. Calandra S, Carulli N, Salvioli G, eds, Elsevier Science Publishers B.V., 83-91.

037 Zichella L, Mancone M, Salmaggi P, Stefanutti C, Tesseri E, Urbinati GC (1985):
The effect of the administration of estrogen on cardiovascular risk factors profile in menopausal women. In: Terapia ormonale in climaterio: rischi e benefici. Fioretti P, Flamigni C, Jasonni VM, Melis GB. Monduzzi Editore, 339-347.

038 Bucci A, Conti R, Del Monaco E, Fiermonte GC, Lalloni L, Mangullo A, Menotti A, Pasquali M, Ricci P, Scarno AG, Sotis GL, Stefanutti C, Triozzi M, Urbinati GC and Ricci G. (1985):
Age-related prevalence of atherosclerotic lesions in the carotid vascular bed. In: Bernardi M, Facchini A, Labo G. (eds), Nutritional and Metabolical Aspects of Aging. Eurage Series Topics in Aging Research in Europe. Vol. 10, pp. 165-175.

039 Bollea MR, Cairella M, Fabbrizzi MP, Fabiani L, Nasta G, Pretaroli AR, Riganelli S, Sacchetti G, Stefanutti C, Zanni AM. (1985):
Folate deficiency in the elderly. Preliminary observations. International Symposium on New Trends in Aging Research. Bologna, Italy, November 6-9. Abstract, p. 168.

040 Cairella M, Calvitti A, Fabbrizzi MP, Fabiani L, Formicuccia P, Marino G, Nasta G, Pretaroli AR, Riganelli S, Stefanutti C, Zanni AM. (1985):
Overweight and obesity in the elderly. Preliminary observations. International Symposium on New Trends in Aging Research. Bologna, Italy, November 6-9. Abstract, p. 167.

041 Zichella L, Stefanutti C, Rocco A, Salmaggi P, Iellamo R, Masala L, Falaschi P, Urbinati GC. (1985):
Sex steroids and lipid metabolism in early menopause. International Symposium on New trends in Aging Research. Bologna, Italy, November 6-9. Abstract, p. 92.

042 Stefanutti C. and the Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO) (1985):
Relationships between gallstone characteristics and clinical course of cholelithiasis. XVIII Riunione Generale Annuale AISF. Roma, Maggio 23-24. Abstract, p. 62.

043 Cairella M, Bollea MR, Nasta G, Stefanutti C, Antonini R, Cantini R, Pontecorvi A, Galatioto S, Di Trapano A, Del Balzo V, Calvitti A, Fabiani L, Fabbrizzi MP, Graziani P, Marino G, Petraroli AR, Riganelli S, Zanni AM. (1986):
Sottoprogetto SP2. Meccanismi di invecchiamento. Problemi nutrizionali nel soggetto anziano. Obiettivo 20/a. Consiglio Nazionale delle Ricerche. Progetto Finalizzato Medicina Preventiva e Riabilitativa . Roma, 17-21 Marzo. Abstract, p. 310.

044 Bucci A, Conti R, Azzarri L, Del Monaco E, Lalloni L, Pasquali M, Ricci P, Scarno AG, Sotis GL, Stefanutti C, Urbinati GC. (1986):
Sottoprogetto SP4. Malattie Degenerative. Linea di ricerca: Studio della Progressione e della Regressione della Lesione Arteriosclerotica con metodiche non invasive. Obiettivo 44. Consiglio Nazionale delle Ricerche. Progetto Finalizzato Medicina Preventiva e Riabilitativa . Roma, 17-21 Marzo. Abstract, p. 427.

045 Urbinati GC, Stefanutti C. ed il Gruppo di Ricerca del Progetto Di.S.Co. (1986):
Sottoprogetto SP4. Malattie Degenerative. Linea di Ricerca: Controllo Comunitario delle Malattie Degenerative. Obiettivo 55. Consiglio Nazionale delle Ricerche. Progetto Finalizzato Medicina Preventiva e Riabilitativa . Roma, 17-21 Marzo. Abstract, p. 499.

046 Stefanutti C. ed il Gruppo di Ricerca del Progetto Di.S.Co. (1986):
Risultati e prospettive. Sottoprogetto SP4. Malattie Degenerative.
Linea di Ricerca: Controllo Comunitario delle Malattie Degenerative. Obiettivo 55: Progetto Distretto Sezze Controllo Comunitario (Di.S.Co.).
I - Caratteristiche generali della popolazione.
Consiglio Nazionale delle Ricerche. Progetto Finalizzato Medicina Preventiva e Riabilitativa . Roma, 17-21 Marzo. CNR - Pubblicazione interna.

047 Stefanutti C. ed il Gruppo di Ricerca del Progetto Di.S.Co. (1986):
Risultati e prospettive. Sottoprogetto SP4. Malattie Degenerative.
Linea di ricerca: Controllo Comunitario delle Malattie Degenerative.
Obiettivo 55: Progetto Distretto Sezze Controllo Comunitario (DI.S.Co). II - Attività di intervento. Consiglio Nazionale delle Ricerche. Progetto Finalizzato Medicina Preventiva e Riabilitativa .
Roma, 17-21 Marzo. CNR - Pubblicazione interna.

048 Bucci A, Conti R, Azzarri L, Del Monaco E, Fiermonte GC, Lalloni L, Menotti A, Pasquali M, Ricci P, Scarno AG, Sotis GL, Stefanutti C, Triozzi M, Urbinati GC and Ricci G. (1986):
Atherosclerotic lesions in carotid vascular beds: B-mode evaluation of prevalence in a sub-sample of free-living population. International Union of Angiology. 14th World Congress. Munich Bavaria, W-Germany, July 6-11. In: Maurer PC, Becker HM, Heidrich H, Hoffmann G, Kriessmann A, Muller-Wiefel H, Pratorius C. (eds.), What is New in Angiology. W.Z.V., Munchen, pp. 288-289.

049 Knuiman JT, Hautvast JGAJ, Van Der Heyden L, Geboers J, Joossens JV, Tornqvist H, Isaksson B, Pitinen P, Tuomiletho J, Poulsen L, Flynn A, Shortt C, Boing H, Yomtov B, Magalhaes E, Angelico F, Stefanutti C, Fazio S, Cantini R, Ricci G, Trichopoulou A, Katapoti Z. (1986):
A multi-centre study on completeness of urine collection in 11 European Centre. I. Hum. Nutr. Clin. Nutr., 40C, 229-237.

050 Bucci A, Lalloni L, Stefanutti C. (1986):
Clinica e diagnostica delle iperlipoproteinemie. IV Corso post-universitario di Angiologia. In: Aggiornamenti in Angiologia. Strano A, Bartolo M, Antignani PL, eds., CIC Edizioni Internazionali, 113-117.

051 Angelico F, Stefanutti C. and the Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO) (1986):
Obesity as a factor associated to gallstone disease (GD): results of two epidemiological surveys. 5th International Congress on Obesity, Jerusalem (Israel), September 14-19. Abstract, p. 103.

052 Bollea MR, Cairella M, Fabbrizzi MP, Fabiani L, Nasta G, Pretaroli AR, Riganelli S, Sacchetti G, Stefanutti C, Zanni AM. (1986):
Folate deficiency in the elderly. Preliminary observations. Clin. Dietol., 13 (3), 193-194.

053 Bucci A, Lalloni L, Chiaromonte C, Stefanutti C, Scarno A, Ricci P, Azzarri L and Ricci G. (1986):
B-mode echography: a new approach to the Epidemiology of Atherosclerotic Disease? In: Atherosclerosis and Cardiovascular Diseases. Lenzi S and Descovich GC, eds, MTP Press Limited, Lancaster, Boston, 529-534.

054 Stefanutti C, Urbinati GC, Perrone G, Mancone M, Pacioni F, Tesseri E, Zichella l, Ricci G. (1986):
Serum lipid profiles in women using three different oral contraceptives: a different atherogenic risk? 6th International Meeting of Atherosclerosis and Cardiovascular Disease. Bologna, Italia, Ottobre 27-29. Abstract, n. 342.

055 Fazio S, Arca M, Angelico F, Calvieri A, Pacioni F, Stefanutti C, Fanelli V. (1986):
Bezafibrate in the treatment of primary hyperlipidemias (HLP): further evaluation. 6th International Meeting of Atherosclerosis and Cardiovascular Disease. Bologna, Italia, Ottobre 27-29. Abstract n. 276.

056 Calvieri A, Stefanutti C, Fazio S, Fanelli V. (1986):
Effects of the diet supplementation with glucomannan fibers on type IIa e IIb monogenic and polygenic hypercolesterolemia: a clinical study. 6th International Meeting of Atherosclerosis and Cardiovascular Disease. Bologna, Italia, Ottobre 27-29. Abstract n. 288.

057 Calvieri A, Stefanutti C, Fazio S, Fanelli V. (1986):
Effects of the diet supplementation with glucomannan fibers on type IIa e IIb monogenic and polygenic hypercolesterolemia: a clinical study. In: Atherosclerosis and Cardiovascular Diseases. Lenzi S. and Descovich G.C. eds, Editrice Compositori, Bologna, 3 (B), 793-798.

058 Fazio S, Arca M, Angelico F, Calvieri A, Pacioni F, Stefanutti C, Fanelli V. (1986):
Bezafibrate in the treatment of primary hyperlipidemias (HLP): further evaluation. In: Atherosclerosis and Cardiovascular Diseases. Lenzi S. and Descovich G.C. eds, Editrice Compositori, Bologna, 3 (B), 847-851.

059 Stefanutti C, Urbinati GC, Perrone G, Mancone M, Pacioni F, Tesseri E, Zichella L, Ricci G. (1986):
Serum lipid profiles in women using three different oral contraceptives: a different atherogenic risk? In: Atherosclerosis and Cardiovascular Diseases. Lenzi S. and Descovich G.C. eds, Editrice Compositori, Bologna 3 (B), 1095-1101.

060 Stefanutti C. and the Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO) (1986):
Multifactorial prevention of CHD and risk of gallstone disease (GD).
CVD Epidemiol. Newsletter, 39. Abstract, p. 69.

061 Angelico F, Arca M, Calvieri A, Del Ben M, Del Monaco E, Di Berardo F, Fabiani L, Fazio S, Montali A, Ricci G, Sibilia L, Stefanutti C, Urbinati GC, Andreatta S, Pannozzo F, Mangullo A. (1986):
A community approach to blood pressure control in children: objectives, design and baseline data of an intervention programme.
CVD Epidemiol. Newsletter, 39. Abstract, p. 70.

062 Bucci A, Conti R, Azzarri L, Del Monaco E, Lalloni L, Menotti A, Pasquali M, Ricci P, Scarno AG, Sotis GL, Stefanutti C, Urbinati GC, Valeo M. (1986):
Ultrasound evaluation (B-mode) of prevalence of carotid atherosclerotic lesions in a subsample of free-living population.
CVD Epidemiol. Newsletter, 40. Abstract, pp. 137-138.

063 Fanelli V, Angelico F, Stefanutti C, Calvieri A, Fazio S. (1986):
Effetti della integrazione della dieta abituale con le fibre di glucomannano nelle iperliproteinemie familiari e sporadiche con fenotipo lipoproteico IIa e IIb.
La Clinica Terapeutica, 119 (1), 17-23.

064 Cairella M, Patruno A, Stefanutti C. ed il Gruppo di Ricerca dell Obiettivo 21/a (U.O.: Roma) del Sottoprogetto SP2 Meccanismi di Invecchiamento - Problemi Nutrizionali nel Soggetto Anziano . Progetto Finalizzato Medicina Preventiva e Riabilitativa . Consiglio Nazionale delle Ricerche (1986):
L obesità e la distribuzione del grasso corporeo in una popolazione di anziani. Epatologia e Malattie del Ricambio, 32 (2), 201-206.

065 Arcieri Mastromattei E, Bucci A, Ciocca S, Conti R, Lalloni L, Mingrone G, Ricci P, Scarno AG, Stefanutti C, Ricci G. (1986):
Acidi grassi liberi, fosfolipidi, acidi biliari e motilità della colecisti in soggetti dispeptici. Gastroenterology Workshop 86.
Rome, Italy, October 22-24. Abstract.

066 Ciocca S, Antonini R, Azzarri L, Bucci A, Cantini R, Conti R, Lalloni L, Mazzarella B, Montali A, Pacioni F, Quattrini B, Ricci P, Scarno AG, Stefanutti C, Valeo M, Zucca A, Ricci G. (1986):
Composizione degli acidi grassi eritrocitari: dati relativi ad un sottocampione di popolazione facente parte di uno studio multicentrico sulla colelitiasi. Gastroenterology Workshop 86. Rome, Italy, October 22-24. Abstract.

067 Bollea MR, Cairella M, Fabbrizzi MP, Fabiani L, Nasta G, Pretaroli AR, Riganelli S, Sacchetti G, Stefanutti C, Zanni AM. (1986):
Folate deficiency in elderly. Preliminary observations.
Clin. Dietol., 13 (3), 193-194.

068 Cairella M, Calvitti A, Fabbrizzi MP, Fabiani L, Formicuccia P, Marino G, Nasta G, Pretaroli AR, Riganelli S, Stefanutti C, Zanni AM. (1986):
Overweight and obesity in the elderly. Preliminary observations.
Clin. Dietol., 13 (3), 195-196.

069 Stefanutti C, Zichella L, Calzolari E, Mancone M, Perrone G, Tesseri E, Urbinati GC. (1986):
Clinical and metabolic evaluation of women using three different oral contraceptives: a comparison.
1st International Congress on Gynecological Endocrinology. Madonna di Campiglio, Trento, Italiano, Marzo 16-22. Abstract p. 128.

070 Stefanutti C, Zichella L, Calzolari E, Mancone M, Perrone G, Tesseri E, Urbinati GC. (1986):
Metabolic evaluation of women using three different oral contraceptives: a comparison.
In: Genazzani AR, Volpe A, Facchinetti F. Gynecological Endocrinology - The proceedings of the 1st International Congress on Gynecological Endocrinology. The Parthenon Publishing Group (1986), pp. 399-403.

071 Ricci G & Stefanutti C. (1987):
Prevalenza e distribuzione geografica della litiasi biliare.
In: Progressi Clinici: Medicina. La Colecisti le vie biliari (I). Gambassi G., Greco A.V., Mingrone G. Piccin Editore - Padova, vol. 2 (5), 205-219.

072 Arca M, Sfefanutti C. and the Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO) (1987):
Erithrocyte fatty acid composition and gallstone disease: results and epidemiological survey.
Am. J. Clin. Nutr., 46, 110-114. IF:5.433

073 Stefanutti C. and the DISCO and GREPCO
Research Groups (1987):
Epidemiology of gallstone disease in Italy: comparison between a rural and urban female population.
It. J. Gastroenterol., 19, 129-133.

074 Stefanutti C. and the Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO) (1987):
Radiologic appearance of gallstones and its relationship with biliary symptoms and awareness of having gallstones. Observations during epidemiological studies. Digestive Diseases and Sciences, 32 (4), 349-353. IF:1.427

075 Stefanutti C, Urbinati GC, Ricci G, Pasquali M, Perrone G. and Research Group of Di.S.Co. , Project (1987):
Cardiovascular risk factors in menopause: prevalence data from a population study. The Di.S.Co. Project community study. (Dati inediti). Simposi Satellite al Fifth International Congress on the Menopause. Roma, 1-4 Aprile. In: Zichella L., Perrone G., Terza età della donna. Prevenzione e terapia in climaterio . Monduzzi Editore (1988), vol. I, pp. 129-142.

076 Tesseri E, Zichella L, Ciocca S, Mancone M, Masala L, Perrone G, Rocco A, Stefanutti C, Urbinati GC. (1987):
La malattia aterosclerotica e la menopausa: relazioni tra gli steroidi sessuali e i lipidi, le lipoproteine e le apolipoproteine plasmatiche. Simposi Satellite al Fifth International Congress on the Menopause; Roma, 1-4 Aprile. In: Zichella L., Perrone G., Terza età della donna. Prevenzione e terapia in climaterio .
Monduzzi Editore (1988), vol. I, pp. 149-156.

077 Perrone G, Tesseri E, Camilli A, Galoppi P, Mazzarella B, Masci A, Stefanutti C, Zichella L. (1987):
Valutazione di alcuni importanti fattori di rischio aterogenico in donne sane in pre- e post-menopausa.
Simposi Satellite al Fifth International Congress on the Menopause. Roma, 1-4 Aprile. In: Zichella L., Perrone G., Terza età della donna. Prevenzione e terapia in climaterio . Monduzzi Editore (1988) vol. I, pp. 515-517.

078 Mancone M, Tesseri E, Masci A, Sorbello M, Stefanutti C, Perrone G, Zucca A, Fabiani L, Zichella L. (1987):
Profilo descrittivo di alcuni fattori di rischio per la patologia cardiovascolare in un gruppo di donne in peri- e post-menopausa. Simposi Satellite al Fifth International Congress on the Menopause. Roma, 1-4 Aprile. Abstract.

079 Stefanutti C, Bucci A, Lalloni L, Scarno AG, Del Monaco E, Sotis GL, Ricci P, Pasquali M, Ricci G. (1987):
Atherosclerotic lesions in menopausal women belonging to a free-living population: echographic (B-mode) detection in the carotid vascular bed. Simposi Satellite al Fifth International Congress on the Menopause. Roma, 1-4 Aprile. Abstract.

080 Stefanutti C, Urbinati GC, Tesseri E, Mancone M, Pasquali M, Venditti P, Pacioni F, Cantini R, Valeo M, Ricci G. and the Sezze Project Research group (1987):
Age-related cardiovascular risk in menopausal and premenopausal women: cross-sectional data. The Sezze Project community study. Simposi Satellite al Fifth International Congress on the Menopause. Roma, 1-4 Aprile. Abstract.

081 Mancone M, Perrone G, Tesseri E, Masci A, Sorbello M, Stefanutti C, Zucca A, Fabiani L, Zichella L. (1987):
Pattern sintomatologico, peso corporeo ed abitudini di vita in un gruppo di donne in peri- e post-menopausa.
Simposi Satellite al Fifth International Congress on the Menopause. Roma, 1-4 Aprile. In: Zichella L., Perrone G., Terza età della donna. Prevenzione e terapia in climaterio . Monduzzi Editore (1988) vol. I, pp. 481-486.

082 Zichella L, Perrone G, Camilli A, Ciocca S, Galoppi P, Mazzarella B, Patella A, Pietrobattista P, Stefanutti C, Tesseri E, Urbinati GC. (1987):
Evaluation of atherogenic risk in healthy pre-menopausal and post-menopausal women: a comparison. 5th Internationl Congress on the Menopause. Sorrento, Aprile 1987. Abstract, p. 201.

083 Zichella L, Camilli A, Cherli N, Fabiani L, Mancone M, Perrone G, Rocco A, Stefanutti
C, Tesseri E, Urbinati GC. (1987):
Sex steroids and lipid metabolism in post-menopausal women. 5th International Congress on the Menopause. Sorrento, April 1987. Abstract, p. 202.

084 Cairella M, Stefanutti C, Ricci G. (1987):
A cross-sectional study on demographic, socio-economic, nutritional and health status in an elderly population.
CVD Epidemiol. Newsletter, 42. Abstract, pp. 93-96.

085 Melchionda N, Enzi G, Caviezel F, Cairella M, Contaldo F, Gatto MRA, Parenti M, Pasquali R, Rago S, Bestaghi L, Di Giorgi A, Pasqui F, Porcu S, Crepaldi G, Labò G, Stefanutti C. (1986):
Correlazioni tra obesità e stato nutrizionale nei soggetti anziani. Studio multicentrico. In: L Obesità: fisiopatologia, clinica, terapia. Atti del IX Congresso dell Unione Italiana contro l Obesità.
Abano Terme, 8-9-10 Maggio. Cleup Editore, pp. 17-33.

086 Bucci A, Azzarri L, Conti R, Del Monaco E, Giampaoli S, Lalloni L, Pacillo L, Pasquali M, Ricci P, Scarno AG, Sotis GL, Stefanutti C, Urbinati GC, Valeo M, Ricci G. (1987):
Incidenza della lesione aterosclerotica carotidea valutata mediante B-scan in un campione di popolazione.
IV Congresso Nazionale della Società Italiana per lo Studio dell Arteriosclerosi (S.I.S.A.). Roma, 14-15 Ottobre 1987. Abstract, p. 7.

087 Stefanutti C, Urbinati GC, Perrone G, Mancone M, Morillo L, Pacioni F, Zichella L, Ricci G. (1987):
Profilo lipidico durante l assunzione di differenti estroprogestinici a basso a dosaggio. IV Congresso Nazionale della Società Italiana per lo Studio dell Arteriosclerosi (S.I.S.A.). Roma, 14-15 Ottobre 1987. Abstract, p. 25.

088 Stefanutti C, Bucci A, Lalloni L, Vivenzio A, Scarno AG, Venditti P, Antonini R, Azzarri L, Valeo M, Ricci P, Ricci G. (1987).
Effetti dell Acipimox sui lipidi e sulle apolipoproteine plasmatiche nelle iperlipoproteinemie primitive di tipo IIa e IV.
IV Congresso Nazionale della Società Italiana per lo Studio dell Arteriosclerosi (S.I.S.A.). Roma 14-15 Ottobre 1987. Abstract, p. 19.

089 Bucci A, Stefanutti C, Lalloni L, Scarno AG, Vivenzio A, Venditti P, Azzarri L, Valeo M, Pacillo L, Antonini R, Ricci P, Ricci G. (1987):
Il Gemfibrozil nel trattamento delle iperlipoproteinemie primitive: uno studio clinico.
IV Congresso Nazionale della Società Italiana per lo Studio dell Arteriosclerosi (S.I.S.A.). Roma 14-15 Ottobre 1987. Abstract, p. 20.

090 Cairella M, Bollea MR, Antonini R, Calvitti A, Cantini R, Del Balzo V, Di Trapano A, Eianti MF, Fabiani L, Fabbrizzi MP, Formicuccia L, Formicuccia P, Gabellini MC, Galatioto S, Graziani P, Marino G, Nasta G, Oliva D, Palmieri F, Patruno A, Pontecorvi A, Pretaroli AR, Riganelli S, Stefanutti C, Zanni AM, Zaccheo SR. (1987):
Prevenzione e trattamento degli squilibri nutrizionali cronici nell anziano.
Alim. Nutr. Metabol., 8 (3), 203-224.

091 Bucci A, Azzarri L, Conti R, Del Monaco E, Giampaoli S, Lalloni L, Pacillo L, Pasquali
M, Ricci P, Scarno AG, Sotis GL, Stefanutti C, Urbinati GC, Valeo M, and Ricci G. (1988):
Incidence of atherosclerotic carotid lesions. B-scan evaluation in a population sample. Lipids in Medicine - Italy - USA Conference.Bologna, April 14-16. Abstract, p. 5.

092 Stefanutti C, Isacchi GC, Antonini R, Bucci A, Cardillo A, Di Nucci GD, Gozzer M, Malagnino F, Masci M, Mazzarella B, Ricci G. (1988):
Selective continuous removal of low-density lipoproteins by dextran-sulfate cellulose column adsorption apheresis in the therapy of familial hypercholesterolemia. 1st International Symposium on Treatment of severe Hypercholesterolemia in the Prevention of CHD. Napoli, Italia, Giugno 16-17. Abstract, p. 24.

093 Stefanutti C, Isacchi GC, Antonini R, Bucci A, Cardillo A, Di Nucci GD, Gozzer M, Malagnino F, Masci M, Mazzarella B, Ricci G. (1988):
Selective continuous removal of low-density lipoproteins by dextran-sulfate cellulose column adsorption apheresis in the therapy of familial hypercholesterolemia.
Contrib. Infus. Ther., 23: 172-182. Beitr Infusionsther.1988; 23:172-82.

094 Urbinati GC, Menotti A, Giampaoli S, Arca M, Stefanutti C. ed il Gruppo di Ricerca del Progetto di Di.S.Co. (1988):
Il progetto Distretto Sezze Controllo Comunitario delle malattie cronico-degenerative (Di.S.Co.): dati relativi all esame iniziale.
Rapporti Istisan (ISSN-0391-1675), 1-186.

095 Stefanutti C, Masala L, Perrone G, Galoppi P, Antonini R, Rocco A, Urbinati GC. (1988):
Steroidi sessuali, lipoproteine, apolipoproteine e rischio cardiovascolare.
Convegno Nazionale Interdisciplinare: Prevenzione e terapia nella terza età della donna .Simeri e Crichi (Catanzaro), Settembre 18-25. In: Zichella L, Valente M, Terza età della donna. Prevenzione e terapia in climaterio. Monduzzi Editore. Vol. II, pp. 239-247.

096 Perrone G, Mancone M, Stefanutti C, Pacioni F, Zichella L. (1988):
Utilizzazione di un contraccettivo orale contenente 20 mcg di etinilestradiolo e 150 mcg di desogestrel in un gruppo di donne. Convegno Nazionale Interdisciplinare: Prevenzione e terapia nella terza età della donna . Simeri e Crichi (Catanzaro), Settembre 18-25. In: Zichella L, Valente M, Terza età della donna. Prevenzione e terapia di climaterio . Monduzzi Editore. Vol. II, pp. 29-34.

097 Bucci A, Azzarri L, Conti R, Del Monaco E, Giampaoli S, Lalloni L, Pacillo L, Pasquali M, Ricci P, Scarno AG, Sotis GL, Stefanutti C, Urbinati GC, Valeo M, Ricci G. (1988):
Atherosclerotic carotid lesions in a sample of free-living population: B-mode evaluation of prevalence, incidence, and natural history. 8th International Symposium on Atherosclerosis. Roma, October 9-13. Workshop Sessions. Abstract, p. 110.

098 Bucci A, Antonini R, Azzarri A, Azzarri L, Del Monaco E, Lalloni L, Pacillo L, Ricci P, Scarno AG, Sotis GL, Stefanutti C, Venditti P, Vivenzio A, Ricci G. (1988):
Lipid-lowering therapy in patients with hyperlipoproteinemia and atherosclerotic
lesions assessed by B-mode ultrasound examination. 8th International Symposium on Atherosclerosis. Rome, October 9-13. Abstract, p. 108.

099 Nin Marques M.I., Stefanutti C., Masci M., Valeo M., Bucci A., Urbinati G.C., Ricci G. (1988):
Changes in blood viscosity on therapy of familial hypercholesterolemia by selective extracorporeal removal of low- density lipoproteins: LDL-apheresis. 8th International Symposium on Atherosclerosis. Rome, October 9-13. Abstract, p. 665.

100 Mazzarella B., Stefanutti C., Masci M., Antonini R., Cardillo A., Gozzer M., Venditti P., Vivenzio A., Ricci G. (1988):
Cardiovascular risk and plasma apolipoprotein changing patterns during low density lipoproteins apheresis. 8th International Symposium on Atherosclerosis. Rome, October 9-13. Abstract, p. 588.

101 Stefanutti C., Isacchi G.C., Antonini R., Bucci A., Cardillo A., Gozzer M., Malagnino F., Masci M., Mazzarella B., Urbinati G.C., Ricci G. (1988):
The non-pharmacological therapy of familial hypercholesterolemia: selective removal of low- density lipoproteins by dextran-sulfate cellulose column adsorption apheresis. 8th International Symposium on Atherosclerosis. Rome, October 9-13. Abstract, p. 891.

102 Venditti P., Antonini R., Azzarri A., Azzarri L., Bucci A., Conti R., Lalloni L., Pacillo L., Ricci P., Scarno A.G., Sotis G.L., Stefanutti C., Valeo M., Vivenzio A., Ricci G. (1988):
Effect of acipimox on plasma lipids and apolipoproteins.
Clinical evaluation in the treatment of types IIa and IV primary hyperlipoproteinemias. 8th International Symposium on Atherosclerosis.Rome, October 9-13. Abstract, p. 987.

103 Vivenzio A., Antonini R., Azzarri A., Azzarri L., Bucci A., Del Monaco E., Lalloni L., Pacillo L., Ricci P., Scarno A.G., Stefanutti C., Valeo M., Venditti P., Ricci G. (1988):
Gemfibrozil in the treatment of types IIa, IIb and IV primary hyerlipoproteinemias. A one-year follow up study.
8th International Symposium on Atherosclerosis. Rome, October 9-13. Abstract, p. 1001.

104 Zichella L., Stefanutti C., Perrone G., Ferrante S., Mancone M., Pacioni F., Pietrobattista P., Urbinati G.C., Ricci G. (1988):
Serum lipid profile in women over thirty-five years using a new oral contraceptive: influence on cardiovascular risk. 8th International Symposium on Atherosclerosis. Rome, October 9-13. Abstract, p. 1064.

105 Perrone G., Mancone M., Stefanutti C., Pietrobattista P., Matelassi P., Zichella L. (1988):
Utilizzazione di un contraccettivo orale contenente 20 mcg. di etinilestradiolo e 150 mcg. di desogestrel in un gruppo di donne in pre-menopausa: effetti sul rischio cardiovascolare.
III Congresso della Società Italiana per lo Studio della Menopausa. Bologna, 16-19 Novembre. In: Il climaterio femminile: esperienze italiane di un decennio . Monduzzi Editore, vol. I, pp. 533-536.

106 Isacchi G.C., Stefanutti C., Antonini R., Cardillo A., Gozzer M., Ferrante G., Malagnino F., Ricci G. (1988):
La terapia non-farmacologica delle iperlipoproteinemie ad alto rischio aterogeno: plasmaferesi selettiva delle lipoproteine a bassa densità (LDL-aferesi). 2° Congresso Nazionale della Società Italiana di Terapia. Palermo, 30 novembre. Abstract, p. 94.

107 Stefanutti C., Isacchi G.C., Bucci A., Masci M., Mazzarella B., Urbinati G.C., Vivenzio A., Ricci G. (1988):
Profilo plasmatico delle lipoproteine e delle apolipoproteine dopo plasmaferesi selettiva delle lipoproteine a bassa densità (LDL-aferesi): modificazione del rischio cardiovascolare.
2° Congresso Nazionale della Società Italiana di Terapia. Palermo, 30 Novembre. Abstract, p. 136.

108 Bucci A., Antonini R., Azzarri L., Conti R., Del Monaco E., Giampaoli S., Lalloni L., Pacillo L., Ricci P., Pasquali M., Scarno A.G., Sotis G.L., Stefanutti C., Urbinati G.C., Valeo M., Ricci G. (1989):
Atherosclerotic carotid lesions in a sample of free-living population: B-Mode Evaluation of Prevalence and Incidence. In: Elsevier Science Publishers B.V.. Atherosclerosis VIII. G. Crepaldi et al. editors. Vol. I, pp. 633-636.

109 Stefanutti C., Perrone G., Galoppi P., Mancone M., Capri O., Valente M. (1989):
Different Hormonal Treatment in Pre- and Post-Menopausal Women: Effect on Cardiovascular Risk.
In: Gynecological Endocrinology. Vol. III (Suppl. 1), FC 242, p. 212. IF: 1.242

110 Stefanutti C., Isacchi G.C., Antonini R., Bucci A., Cardillo M.A., Ferrante S., Gozzer M., Malagnino F., Masci M., Mazzarella B., Ricci G. (1989):
Low Density Lipoprotein Apheresis (LDL-A) Possibility to Control Severe Familial Hypercholesterolemia (FH) and Non-Familial Hyperlipoproteinemia (N-F HPL) Progression to Arteriosclerosis. 5th European Symposium on Metabolism.
Padua, May 15-17. Abstract, p. 24.

111 Stefanutti C., Santulli M., Antonini R., Bucci A., Barbiera C., Di Nucci G.D., Ricci G. (1989):
Dextransulfate Cellulose Low Density Lipoprotein Affinity Apheresis (DSC-LDL/A): Haemorheological Aspects and Haemocoagulation System. International Symposium on: Biotechnology of Dyslipoproteinemias: Clinical Applications in Diagnosis and Control. Milan, May 8-10. Abstract, p. 104.

112 Stefanutti C., Isacchi G.C., Bucci A., Cardillo M.A., Gozzer M., Granati L., Malagnino F., Masci M., Mazzarella B., Pacioni F., Vivenzio A., and Ricci G. (1989):
Dextransulfate Cellulose LDL-Affinity Apheresis (DSC-LDL/A) in the Treatment of Severe Familial Hypercholesterolemia (FH) and Non-Familial Hyperlipoproteinemia (N-F HLP): Clinical Report on Twelve Cases. In: Second International Symposium: Treatment of Severe Hypercholesterolemia in the Prevention of Coronary Heart Disease. Münich, June 29-30. Abstract, p. 15.

113 Stefanutti C., Bucci A., Azzarri L., Giampaoli S., Lalloni L., Ricci P., Scarno A.G., Urbinati G.C., Ricci G. (1989):
Total Cholesterol/HDL-Cholesterol Ratio and Risk of Asymptomatic Carotid Lesions (ACL) in a Free-Living Population Sample. In: 2nd International Conference on Preventive Cardiology and the 29th Annual Meeting of the AHA Council on Epidemiology. Washington (USA), June 18-22. Abstract, p. 30-A6.

114 Stefanutti C., Urbinati G.C., and Research Group of the Di.S.Co. Project (1989):
Effects of an Educational Community-Based Program on Arterial Hypertension: the DI.S.Co. Project. In:2nd International Conference on Preventive Cardiology and the 29th Annual Meeting of the AHA Council on Epidemiology. Washington (USA), June 18-22. Abstract, p. A6/451.

115 Stefanutti C., Bucci A. and Research Group of the DI.S.Co. Project (1989):
Effects on an Intervention Program on Nutritional Education: the DI.S.Co. Project. In: 2nd International Conference on Preventive Cardiology and the 29th Annual Meeting of the AHA Council on Epidemiology. Washington (USA), June 18-22. Abstract, p. A96/547.

116 Stefanutti C., Urbinati G.C., and Research Group of the DI.S.Co. Project. (1989):
Prevention and control of Diabetes Mellitus in the DI.S.Co. Project. In: 2nd International Conference on Preventive Cardiology and the 29th Annual Meeting of the AHA Council on Epidemiology. Washington (USA), June 18-22. Abstract, p. A97/553.

117 Stefanutti C., Arca M., and Research Group of the DI.S.CO. Project (1989):
Effects of a community-based intervention trial focused on smoking habits. In: 2nd International Conference on Preventive Cardiology and the 29th Annual Meeting of the AHA Concil on Epidemiology. Washington (USA), June, 18-22. Abstract, p. A99/569.

118 Stefanutti C., Bucci A., Azzarri A., Azzarri L., Conti R., Del Monaco E., Giampaoli S., Lalloni
L., Pacillo L., Paquali M., Ricci P., Scarno A.G., Sotis G.L., Urbinati G.C., Valeo M., (1989):
Smoking Habits and Risk of Asymptomatic Carotid Lesions (ACL) in a Free-Living Population Sample. In: International Union of Angiology. 15th World Congress. Rome, 17th-22nd September. Abstract, p. 956/78.

119 Stefanutti C., Isacchi G.C., Bucci A., Gozzer M., Malagnino F., Masci M., Mazzarella B., Vivenzio A., Ricci G. (1989):
Treatment of Severe Hypercholesterolemia and Hypertrigliceridemia in the Prevention of Arteriosclerosis Ischaemic Complication by Low Density Lipoprotein Apheresis (LDL-A). In: International Union of Angiology. 15th World Congress. Rome, 17th-22nd September, Abstract, p. 946/474.

120 Bucci A., Antonini R., Azzarri L., Conti R., Del Monaco E., Giampaoli S., Lalloni L., Pacillo L., Ricci P., Pasquali M., Scarno A.G., Sotis G.L., Stefanutti C., Urbinati G.C., Valeo M., Ricci G. (1989):
Atherosclerotic carotid lesions in a sample of free-living population: B-Mode Evaluation of Prevalence and Incidence. In: Elsevier Science Publishers B.V.. Atherosclerosis VIII. G. Crepaldi et al. editors. Vol. I, pp. 633-636.

121 Stefanutti C., Isacchi G.C., Ricci G. (1989):
Variables involved in the management of severe hyperlipoproteinemias by combined drug and LDL-apheresis treatment. 7th International Meeting on Atherosclerosis and Cardiovascular Disease. Bologna, September, 25-26-27. Abstract, p. 227.

122 Stefanutti C., Isacchi G.C., Ricci G. (1989):
Variables involved in the management of severe hyperlipoproteinemias by combined drug and LDL-apheresis treatment. In: Atherosclerosis and Cardiovascular Disease 7th International Meeting. Eds.: G.C. Descovich, A. Gaddi, G.L. Magri & S. Lenzi; 64, 499-505.

123 Malagnino F., Stefanutti C., Isacchi G.C., Mazzarella B ., Vivenzio A., Masci M., Pupella S., Antonini R., Gozzer M., Prosperi G., Granati L., Cardillo M.A., Urbinati G.C., Bucci A. and Ricci G. (1989):
Plasma-exchange (PE) and dextransulfate cellulose LDL-affinity apheresis (DSC-LDL/A) in the treatment of severe hyperlipoproteinemia: a comparison. 7th International Meeting on Atherosclerosis and Cardiovascular Disease. Bologna, September, 25-26-27. Abstract, p. 314.

124 Stefanutti C., Bucci A., Vivenzio A., Antonini R., Scarno A.G., Lalloni L., Ricci P. (1989):
Gemfibrozil treatment of type IIa, IIb, and IV primary hyperlipoproteinemia: a 1-year follow up study.
X International Symposium on Drugs Affecting Lipid Metabolism. Houston (USA), November 8-11. Abstract p.13.

125 Angelico F., Del Ben M., Stefanutti C. and the Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO) (1989):
Obesity as a risk factor for gallstone disease: results of a six-years follow-up study. Inter. J. Obesity, 13 (suppl. 1), p. 24. IF: 3.459

126 Angelico F., Stefanutti C. and the Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO) (1989):
Risk factors for gallstone disease in the GREPCO studies.
It. J. Gastroenterology, 21 (5): 9.

127 Attili A. F., Lalloni L., Stefanutti C. and the Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO) (1989):
Natural history of gallstones (GS). A four to six year follow-up study of asymptomatic and symptomatic patients.
It. J. Gastroenterology, 21 (5): 19.

128 Spagnolo A., Menotti A., Giampaoli S., Morisi G., Buongiorno A., Urbinati G.C., Righetti G., Ricci G., Stefanutti C. and the members of 6 Research Groups (1989):
High density lipoprotein cholesterol distribution and predictive power in some Italian populations studies. Eur J. Epidemiol. 0392-2990, 5 (3), 328-335. IF: 0.902

129 Stefanutti C., Isacchi G.C., Vivenzio A., Masci M., Venditti P., Gozzer M., Bucci A., Ricci G. (1990):
Plasma lipoprotein, apolipoprotein and fibrinogen levels during hypocholesterolemic treatment with multiple drug therapy and plasmapheresis. International Symposium on Lipoprotein Metabolism and Lipid Lowering Agents. The Hague (The Netherlands), 26th February to 2nd March. Abstract, p. F-041.

130 Stefanutti C., Fanelli V., Mazzarella B., Isacchi G.C., Vivenzio A., Masci M., Ricci G. (1990):
Treatment of severe hypercholesterolemia by combining drug and LDL-apheresis. A clinical approach. 5e Colloque International de la Fondation de Recherche sur l Atherosclerose. Bruxelles (Belgique) 14-15-16 Mars.Abstract, p. 78.

131 Stefanutti C., Vivenzio A., Ceratti L., Venditti P., Zucca A., Bucci A., Ricci G. (1990):
Effetti della colestiramina microporosa sui livelli sierici delle lipoproteine nell ipercolesterolemia familiare.
III Congresso Nazionale della Società Italiana di Terapia.Giugno 17-20, Padova, Italia. Abstract.

132 Stefanutti C., Isacchi G.C., Masci M., Vivenzio A., Mazzarella B., Malagnino F., Gozzer M., Bucci A., Ricci G. (1990):
Dextran sulfate cellulose LDL-affinity apheresis (DSC-LDL/A) in the treatment of Severe familial hypercholesterolemia and non-familial hyperlipoproteinemia. A clinical report on twelve cases. In: Treatment of severe Hypercholesterolemia in the Prevention of Coronary Heart Disease 2. Gotto A.M. Jr., Mancini M., Richter W.O., Schwandt P., eds. Basel, Karger, pp. 253-267.

133 Stefanutti C., Isacchi G.C., Mazzarella B., Vivenzio A., Masci M., Gozzer M., Ricci G. (1990):
Low-densiy lipoprotein apheresis and plasma-exchange in the management of severe hyperlipoproteinemias. Clinical report on twelve cases. 3rd International Congress of World Apheresis Association. Amsterdam (The Netherlands), April 9-12. Abstract, p. TU-PO-B/42.

134 Stefanutti C., Vivenzio A., Mazzarella B., D Angelo S., Cavallaro A., Ricci G. (1990):
Il trattamento extracorporeo mediante plasma-exchange della sindrome di Raynaud: un caso clinico. Volume degli Atti del XIX Congresso Nazionale della Società Italiana di Chirurgia d Urgenza, Roma, 18-21 Novembre, pp. 795-808.

135 Stefanutti C., Vivenzio A., Nigri A., Di Giacomo S., Ricci G. (1990):
Il trattamento extracorporeo della ipercolesterolemia familiare omozigote mediante plasmaferesi selettiva delle lipoproteine aterogene (LDL-aferesi). Volume degli Atti del XIX Congresso Nazionale della Società Italiana di Chirurgia d Urgenza, Roma, 18-21 Novembre, pp. 1-3.

136 Stefanutti C., Mazzarella B., Vivenzio A., Bucci A., Ricci G. (1990):
Serum Lp(a) profile in patients with familial hypercholesterolemia treated by LDL-apheresis. International Symposium on Multiple Risk Factors in Cardiovascular Disease.
Washington, DC, USA, December 10-12. Abstract, p. 23.

137 Stefanutti C., Mazzarella B., Vivenzio A., Nigri A., Bucci A. & Ricci G. (1990):
Extracorporal atherogenic lipoprotein removal in patient with homozygous familial hypercholesterolemia.Treatment of Severe Dyslipoproteinemia in the Prevention of Coronary Heart Disease. 3rd International Symposium. Münich, October 18-19; Abstract, p. 80.

138 Bucci A., Sotis G.L., Del Monaco E., Azzarri A., Conti R., Giampaoli S., Lalloni L., Pacillo L., Pasquali M., Ricci P., Scarno A.G., Stefanutti C., Urbinati G.C., Valeo M., Ricci G. (1990):
Asymptomatic atherosclerotic carotid lesion and ECG patterns of ischemic heart disease.
CVD Epidem. Newsletter. Council on Epidemiology - American Heart Association n. 46, Abstract, p. 95.

139 Bucci A., Azzarri L., Azzarri R., Conti R., Del Monaco E., Gianpaoli S., Gioia S., Lalloni L., Pacillo M., Pasquali M., Ricci P., Rumi E., Scarno A.G., Sotis G.L., Stefanutti C., Urbinati G.C., Valeo M., Ricci G. (1990):
Smoking habits and risk of atherosclerotic carotid lesions in a free-living population sample.
CVD Epidem. Newsletter Council on Epidemiology - American Heart Association n. 46, Abstract p. 95.

140 Stefanutti C., Galoppi P., Perrone G., Vivenzio A., Fraone N., Capri O., Zichella L., Ricci G. (1990):
Cardiovascular risk profile and risk of osteoporosis in perimenopausal women: cross-sectional finding on outpatient basis. CVD Epidem. Newsletter. Council on Epidemiology-American Heart Association n. 46, Abstract, p. 96.

141 Stefanutti C., Perrone G., Capri O., Galoppi P., Anelli G., Vivenzio A., Venditti P., Zichella L. (1990):
Iperlipoproteinemia e rischio di osteoporosi: studio clinico su un gruppo di pazienti ambulatoriali in età perimenopausale.
Atti del LXVII Congresso Nazionale della Società Italiana di Ginecologia ed Ostetricia. Ed. Clas International. Brescia, Settembre; pp. 673-674.

142 Stefanutti C., Zichella L., Perrone G., Capri O., De Angelis C., Galoppi P., Valente L., D Ubaldo C. (1990):
Transdermal and oral replacement therapy in postmenopausal women: effect on serum lipids and lipids and lipoproteins after 18 months of treatment. 6th International Congress on Menopause.Bangkok, Thailand, 29 Ottobre - 2 Novembre, Abstract, p. 285.

143 Stefanutti C., D Ubaldo C., Perrone G., Galoppi P., Goglia P.B., Vivenzio A., Capri O., Zichella L., Ricci G. (1991).
Iperlipoproteinemia e rischio di osteoporosi in un campione di donne in età perimenopausale: uno studio clinico.V Congresso Nazionale della Società Italiana per lo Studio dell Aterosclerosi. Roma, 28 Febbraio - 2 Marzo; Abstract, p. 35.

144 Bosco G., Stefanutti C., Mazzarella B., Giglioni E., Cerratti L., Vivenzio A., Colloridi V., Ricci G. (1991).
Le ipercolesterolemie mono- e poligeniche in età pediatrica: aspetti preventivi e terapeutici. Uno studio clinico.V Congresso Nazionale della Società Italiana per lo Studio dell Aterosclerosi. Roma, 28 Febbraio - 2 Marzo; Abstract, p. 43.

145 Stefanutti C., Vivenzio A., Mazzarella B., Nigri A., Bruni P., D Angelo S., Ricci G. (1991):
Il trattamento extracorporeo della ipercolesterolemia familiare omozigote mediante plasmaferesi selettiva delle lipoproteine aterogene (LDL-aferesi). V Congresso Nazionale della Società Italiana per lo Studio dell Aterosclerosi. Roma, 28 Febbraio - 2 Marzo, Abstract, p. 57.

146 Perrone G., Capri O., Stefanutti C., Galoppi P., Pacioni F., Anelli G., Zichella L., Ricci G. (1991):
Effetti a lungo termine della terapia ormonale sostitutiva orale e transdermica sul profilo plasmatico delle lipoproteine in un campione di donne. V Congresso Nazionale della Società Italiana per lo Studio dell Aterosclerosi. Roma, 28 Febbraio - 2 Marzo; Abstract, p. 61.
147 Stefanutti C., Vivenzio A., Mazzarella B., Masci M., Cardillo A., Gozzer M., Isacchi G.C., Ricci G. (1991):
Profilo plasmatico della Lp(a) in pazienti affetti da ipercolesterolemia familiare sottoposti a LDL-aferesi. Società Italiana di Emaferesi. V Congresso Nazionale Salice Terme (PV), 8-10 Maggio; Abstract, p. 61.

148 Stefanutti C., Vivenzio A., Bruni P., Cerratti L., Antonini R., Ricci G. (1991):
Il trattamento extracorporeo mediante plasmaferesi della Sindrome di Raynaud: un caso clinico. Società Italiana di Emaferesi. V Congresso Nazionale Salice Terme (PV), 8-10 Maggio; Abstract, p. 67.

149 Stefanutti C., Di Giacomo S., Vivenzio A., Ceratti L., Antonini R., Clemente G., Bucci A., Ricci G. (1991):
Gemfibrozil alone and combined with cholestyramine in the treatment of primary hyperlipoproteinemia. 57th Eas Meeting. Lisbona, Portogallo, 22-25 Maggio. Abstract, p. 64.

150 Stefanutti C., Perrone G., Galoppi P., Capri O., Di Giacomo S., Pacioni F., Zichella L., Ricci G. (1991):
Long-term effect on plasma lipid and lipoprotein profile of transdermal and oral replacement therapy in postmenopausal women. 57th Eas Meeting. Lisbona, Portogallo, 22-25 Maggio. Abstract, p. 151.

151 Stefanutti C., Di Giacomo S., Vivenzio A., Ceratti l., Antonini R., Clemente G., Bucci A., Ricci G. (1991):
Gemfibrozil alone and combined with cholestyramine in the treatment of primary hyperlipoproteinemia. Molecular Biology of Atherosclerosis. Halpern M. J. (Ed.). pp. 583-586.

152 Stefanutti C., Perrone G., Galoppi P., Capri O., Di Giacomo S., Pacioni F., Zichella L., Ricci G. (1991):
Long-term effect on plasma lipid and lipoprotein profile of transdermal and oral replacement therapy in postmenopausal women. Molecular Biology of Atherosclerosis. Halpern M. J. (Ed.). pp. 365-368.

153 Perrone G., Stefanutti C., Capri O., Galoppi P., Di Giacomo S., Mazzarella B., D Ubaldo C., Zichella L. (1991):
Effect of transdermal estrogen therapy on serum lipids and lipoproteins in hypercholesterolemic women.
2nd Annual Meeting of The North American Menopause Society Montreal, 25-28 Settembre. Abstract, p. 121.

154 Zichella L., Perrone G., Capri O., Galoppi P., Anelli G., Stefanutti C., Ricci G. (1991):
Valutazione degli effetti dell estrogenoterapia sul profilo plasmatico dei lipidi e delle lipoproteine in donne normocolesterolemiche ed ipercolesterolemiche. Atti del LXVIII Congresso della Societa Italiana di Ginecologia ed Ostetricia. Abstract

155 Stefanutti C., Mazzarella B., Godi L., Vivenzio A., Ricci G. (1991):
Effect of L-carnitine on plasma lipoprotein fatty acids pattern in patients with primary hyperlipoproteinemia. 9th International Symposium on Atherosclerosis. Rosemont, Illinois, USA, 6-11 Ottobre. Abstract, p. 31.
156 Bertolini S., Coviello D.A., Masturzo M., Ghisellini M., Stefanutti C., Pachì A., Ajmar F., Calandra S. (1991):
Chorionic DNA examination for familial hypercholesterolemia (FH) during the tenth week of pregnancy in a family which previously had an homozygous offspring. 9th International Symposium on Atherosclerosis. Rosemont, Illinois, USA, 6-11 Ottobre. Abstract, p. 141.

157 Stefanutti C., Clemente G., Di Giacomo S., Mazzarella B., Vivenzio A., Bucci A., Ricci G. (1991):
Long-term evaluation of high dosage administration of simvastatin in patients with familial hypercholesterolemia. 9th International Symposium on Atherosclerosis. Rosemont, Illinois, USA, 6-11 Ottobre. Abstract, p. 181.

158 Bosco G., Stefanutti C., Giglioni E., Di Vita D., Bastianon V., Colloridi (1991):
Le ipercolesterolemie mono e poligeniche in età pediatrica: risultati preliminari di uno studio clinico-terapeutico.
G. Ital. Cardiol., Vol. 21, Suppl. 2, C. 17.

159 Bosco G., Ventriglia F., Stefanutti C., Borzaga U., Belardi C., Colloridi V. (1991):
L ipercolesterolemia familiare omozigote: efficacia della plasmaferesi nella prevenzione e possibile risoluzione delle alterazioni coronariche. Simposio Aterosclerosi nell eta pediatrica della Societa Italiana di Cardiologia Pediatrica. Roma, 12 Settembre. Abstract.

160 Stefanutti C., Vivenzio A., Di Giacomo S., D Angelo S;, Cerratti L., Mazzarella B., Ricci G. (1991):
Effetti della LDL-aferesi sui livelli plasmatici della Lp(a).
Workshop sulla LDL-Aferesi. Documento della Consensus Conference. Ostuni (BR), 19 Ottobre. Atti.

161 Stefanutti C., Antonini R., Vivenzio A., Mazzarella B., Di Giacomo S., Ricci G. (1992):
Hypolipidemic effects of pravastatin, simvastatin and gemfibrozil in primary hyperlipoproteinemia. Conference on Atherosclerosis. Boston, IBC U.S.A., February 10-11. Abstract.

162 Bertolini S., Coviello D.A., Masturzo P., Ghisellini M., Stefanutti C., Lelli N., Calandra S. (1992):
Chorionic DNA analysis for the pre-natal diagnosis of familial hypercholesterolemia (FH). 61st European Atherosclerosis Society Congress. Nizza (France), February 2-5. Abstract, p. 41.

163 Stefanutti C., Vivenzio A., Perrone G., Galoppi P., Capri O., Di Giacomo S., Ricci G., Zichella L. (1992):
Profilo sierico delle lipoproteine in donne in climaterio affette da ipercolesterolemia primitiva: effetti della terapia ormonale sostitutiva transdermica. IV Congresso Nazionale della Società Italiana di Terapia. Roma, 27-29 Febbraio. Abstract, p. 15.

164 Stefanutti C., Vivenzio A., Di Giacomo S., Bianchi M.A., Mazzarella B., Ricci G. (1992):
Long-term treatment with pravastatin and simvastatin at high dosage in primary hyperlipoproteinemia. XI International Symposium on Drugs Affecting Lipid Metabolism. Firenze, 13-16 Maggio. Abstract, p. 24.
165 Zichella L., Perrone G., Stefanutti C., Capri O., Galoppi P., Barillaro F., Bianchi A.M. (1992):
Hormonal replacement therapy in hypercholesterolemic women. Menopause Update 1992. International Workshop Procedings. Como, Italia, 13-15 Maggio. pp. 219-222.

166 Stefanutti C., Russo A., Pretagostini R., Lopez A., Quaglia M.G. (1992):
Role of extracorporal removal techniques in clinical toxicology. XV International Congress of the European Association of Poison Centres and Clinical Toxicologists.
Istanbul, Türkiye, 25-27 maggio. Abstract, p. 84.

167 Stefanutti C., Mazzarella B., Di Giacomo S., Vivenzio A., Bucci A.,
Isacchi G.C., Ricci G. (1992):
Long-term treatment of homozygous familial hypercholesterolemia with selective and conventional plasmapheresis. 4th International Congress of the World Apheresis Association. Sapporo, Japan, June 3-5. Abstract, p. 167.

168 Stefanutti C., Vivenzio A., D Angelo S., Di Giacomo S., Alessandri C., Ricci G. (1992):
Plasma Lp(a) profile in patients with familial hypercholesterolemia treated by dextransulfate cellulose LDL-apheresis and plasma-exchange.4th International Congress of the World Apheresis Association. Sapporo, Japan, June 32-5. Abstract, p. 27.

169 Antonelli M., Vivino G., Corradini S., Cannata F., Russo A., Stefanutti C. (1992):
Are extracorporeal techniques a valuable tool for removal of mediators in septic patients? 4th International Congress of the World Apheresis Association. Sapporo, Japan, 3-5 June. Abstract, p. 297.

170 Stefanutti C., Mazzarella B., Vivenzio A., Nigri A., Bucci A., Ricci G. (1992):
Extracorporeal atherogenic lipoprotein removal in patients with homozygous familial hypercholesterolemia. In: Treatment for Severe Dyslipoproteinemia in the Prevention of Coronary Heart Disease. 3. Eds. Gotto A.M., Mancini M., Richter W.O., Schwandt P. Karger, Basel, pp. 333-344.

171 Stefanutti C., Vivenzio A., Mazzarella B., Alessandri C., Colombo C., Di Giacomo S. (1992):
Lipoprotein and haemocoagulatory parameters during familial hypercholesterolemia. 4th International Symposium on Treatment of Severe Dyslipoproteinemia in the Prevention of Coronary Heart Disease. Münich (Germany), October 22-23. Abstract, p. 48.

172 Stefanutti C., Mazzarella B., Vivenzio A., Colombo C., Bucci A., Ricci G. (1992):
Long-term treatment of homozygous familial hypercholesterolemia with selective and conventional plasmapheresis.
Therapeutic Plasmapheresis (XII), 471-479.

173 Stefanutti C., Vivenzio A., Di Giacomo S., Colombo C., Alessandri C., Ricci G. (1992):
Plasma Lp(a) profile in patients with familial hypercholesterolemia treated by dextransulfate cellulose LDL-apheresis and plasma-exchange.
Therapeutic Plasmapheresis (XII), 471-479.

174 Stefanutti C., Vivenzio A. (1993):
La prima diagnosi prenatale di ipercolesterolemia familiare mediante tecniche di biologia molecolare.
La Clinica Terapeutica, 143: 99-103. IF:0.177

175 Bertolini S., Calandra S., Stefanutti C., Pachi A., Ricci G., Torci F., Ghisellini M., Tiozzo R., Coviello D.A., Masturzo P., Zambelli F. (1993):
Chorionic DNA analysis for the pre-natal diagnosis of familial hypercholesterolemia. Human Genetics, 92: 424-426. IF: 4.328

176 Stefanutti C., Vivenzio A., Mazzarella B., Di Giacomo S., Colombo C., Ricci G., Alessandri C., Bianciardi G., Carducci A., Tanganelli P., Weber G.. (1993):
Lipoprotein and haemocoagulatory parameters during therapeutic plasmapheresis in homozygous and heterozygous familial hypercholesterolemia.In: Treatment of Severe Dyslipoproteinemia in the Prevention of Coronary Heart Disease. 4.
Gotto A.M.jr., Mancini M., Richter W.O., Schwandt P. (Eds.) Basel, Karger, 223-233.

177 Stefanutti C., Vivenzio A., Di Giacomo S. (1993):
La LDL-aferesi: indicazioni terapeutiche.
Metabolismo oggi, Vol. 10, No. 2. pp. 44-54.

178 Stefanutti C., Vivenzio A., Mazzarella B., Colombo C., Di Giacomo S., Alessandri C., Ricci G. (1993):
Pattern of red blood cell and platelet cholesterol and fatty acids of two patients with homozygous familial hypercholesterolemia with LDL-apheresis. 61st Meeting of European Atherosclerosis Society. Capri, Italia, 13-19 Maggio. Abstract, p. 223.

179 Stefanutti C., Vivenzio A., Di Giacomo S., Mazzarella B., Lucani G.,
Colombo C. (1993):
Oltre 3 e 5 anni di trattamento dell ipercolesterolemia familiare omozigote mediante plasmaferesi terapeutica. VI Congresso Nazionale della Società Italiana di Emaferesi. Montesilvano Lido (PE), Italia, 1-4 Giugno. Abstract, p. 119.

180 Bianciardi G., Stefanutti C., Tanganelli P., Mazzarella B., Carducci A., Vivenzio A., Weber G., Alessandri C.. (1993):
Ultrastructural morphometry of leukocytes in human patients with hypercholesterolemia. 62nd European Atherosclerosis Society Congress. Jerusalem, Israel, September 5-9. Abstract, p. 92.

181 Stefanutti C., Vivenzio A., Mazzarella B., Di Giacomo S., Colombo C., Alessandri C.. (1993):
Monogenic hypercholesterolemia: a new system for cascade filtration low density lipoprotein apheresis vs dextrane sulfate cellulose LDL-apheresis and plasma-exchange. IX Scientific Congress of European Society for Haemapheresis in association with the British Blood Transfusion Society. Aberdeen, (U.K.), September 12-15. Abstract, p. 31.

182 Perrone P., Stefanutti C., Capri O., Galoppi P., Anelli G., Lucani G., Di Giacomo S., Zichella L. (1993):
Plasma lipoprotein and Lp(a) profile in hypercholesterolemic women treated with hormonal replacement therapy.
International Symposium on Women s Health in Menopause Behaviour, Cancer, Cardiovascular Disease Hormone Replacement Therapy. Milano (Italia), 26-29 settembre. Abstract, p. 63.

183 Vivenzio A., Stefanutti C., Perrone P., Galoppi P., Mazzarella B., Anelli G., Di Giacomo S., Colombo C., Bianchi M.A., Alessandri C., Ricci G. (1993):
Effetti della terapia ormonale sostitutiva sul profilo plasmatico delle lipoproteine e della Lp(a) in donne ipercolesterolemiche in menopausa. VII Congresso Nazionale della Società Italiana per lo Studio della Arteriosclerosi. Torgiano (PG), Italia, 28-30 Ottobre. Abstract, p. 73.

184 Stefanutti C., Bianciardi G., Colombo C., Mazzarella B;, Carducci A., Vivenzio A., Tanganelli P., Alessandri C., Di Giacomo S., Weber G., Ricci G.. (1993):
Valutazione mediante morfometria ultrastrutturale degli elementi figurati della serie leucocitaria in pazienti con ipercolesterolemia monogenica. VII Congresso Nazionale della Società Italiana per lo Studio della Arteriosclerosi.Torgiano (PG), Italia, 28-30 Ottobre. Abstract, p. 67.

185 Calandra S., Bertolini S., Cattin L., Valenti M., Stefanutti C. (1993):
FH Trieste e FH Avellino: due nuove mutazioni nell esone 7 del gene del recettore-LDL. VII Congresso Nazionale della Società Italiana per lo Studio della Arteriosclerosi. Torgiano (PG), Italia, 28-30 Ottobre. Abstract, p. 30.

186 Stefanutti C., Vivenzio A., Lucani G., Di Giacomo S., Bianchi M.A., Ricci G. (1994):
Simvastatin and pravastatin: a daily dose of 40 mg in the long-term treatment of primary hypercholesterolemia.
Curr. Ther. Res. 55: 4, pp. 446-454. IF: 0.324

187 Lelli N., Garuti R., Pedrazzi P., Ghisellini M., Simone M.L., Tiozzo R., Cattin L., Valenti M., Rolleri M., Bertolini S., Stefanutti C., Calandra S. (1994):
A new missense mutation (Cys 297- - Phe) of the low- density lipoprotein receptor in talian patients with familial hypercholesterolemia (FH Trieste).
Human Genetics, 93: 538-540. IF: 4.328

188 Stefanutti C., Vivenzio A., Colombo C., Di Giacomo S, Mazzarella B.. (1994):
LDL-apheresis in pediatric patients with severe hypercholesterolemia. 5th International Congress of Wold Apheresis Association Houston, Texas U.S.A. March 9-12. Abstract, p. 183.

189 Stefanutti C., Vivenzio A., Colombo C., Di Giacomo S., Mazzarella B.. (1994):
LDL-apheresis in pediatric patients with severe hypercholesterolemia.
J Clin Apheresis 9: 1, 88. IF: 1.245

190 Stefanutti C., Vivenzio A., Di Giacomo S., Lucani G.C., Colombo C. (1994):
LDL-aferesi: prospettive di ricerca.
In: Hearing su: L aferesi terapeutica: necessità di ricerca finalizzata. Roma, 28 ottobre. Progetto Finalizzato. Prevenzione e Controllo dei Fattori di Malattia - FATMA . Consiglio Nazionale delle Ricerche. pp. 83-88.

191 Bianciardi G., Carducci A., Tanganelli P., Brogi M., Weber G., Stefanutti C., Mazzarella B., Vivenzio A., Di Giacomo S., Alessandri C. (1994):
Studio morfometrico ultrastrutturale di leucociti in pazienti con ipercolesterolemia familiare sottoposti a LDL-aferesi. VIII Congresso Nazionale della Società Italiana per lo Studio dell Arteriosclerosi. Roma, 8-9-10 Dicembre. Abstract, p. 8.

192 Rolleri M., Lelli N;, Garuti R., Masturzo P., Ginocchio E., Stefanutti C., Orsecchini G., Calandra S., Bertolini S. (1994):
Delezioni del gene del recettore LDL(LDL-R) responsabili di ipercolesterolemia familiare (FH) in Italia. VIII Congresso Nazionale della Società Italiana per lo Studio dell Arteriosclerosi. Roma, 8-9-10 Dicembre. Abstract, p. 49.

193 Bertolini S., Garuti R., Lelli W., Rolleri M., Tiozzo R.M., Ghisellini M., Simone M.L., Masturzo P., Elicio N.C., Stefanutti C., Coviello D., Carabbio C., Orecchini G., Calandra S. (1995):
Four novel partial deletions of LDL-receptor gene in Italian patients with familial hypercholesterolemia.
Arteriosclerosis, Thrombosis, and Vascular Biology, 15(1): 81-88. IF: 7.432

194 Stefanutti C., Vivenzio A., Colombo C., Di Giacomo S., Mazzarella B., Berni A., Nigri A., Koga N. (1995):
Treatment of homozygous and double heterozygous familial hypercholesterolemic children with LDL-apheresis.
Int. J. Artif. Organs, 18(2): 103-110. IF: 1.065

195 Stefanutti C., Vivenzio A., Colombo C., Di Giacomo S., Mazzarella B., Berni A., Nigri A., Koga N. (1995):
LDL-apheresis in pediatric patients with severe hyperlipoproteinemia.
J. Clin. Apheresis, 10: 101-102. IF: 1.245

196 Bianciardi G., Tanganelli P., Carducci A., Contorni M., Weber G., Stefanutti C., Mazzarella B., Vivenzio A., Di Giacomo S., Alessandri C. (1995):
Morfometria ultrastrutturale di linfociti e monociti in pazienti con ipercolesterolemia familiare sottoposti a trattamenti terapeutici. IX Congresso Nazionale della Società Italiana per lo Studio dell Arteriosclerosi. Roma, 27-28-29 Novembre. Abstract, p. 10.

197 Stefanutti C., Vivenzio A., Di Giacomo S., Colombo C., Ferrazzoli I. (1995):
LDL-aferesi: indicazioni alle diverse metodiche. SIdE. VII Congresso Nazionale. Napoli, 16-19 Maggio. Abstract, p. 38.

198 Stefanutti C., Vivenzio A., Di Giacomo S., Colombo C., Mazzarella B., Alessandri C., Fontana M., Grassi M., Ricci G. (1995):
Trattamento dell ascite tesa nella cirrosi epatica mediante ascitoaferesi. SIdE. VII Congresso Nazionale. Napoli, 16-19 Maggio. Abstract, p. 97.

199 Stefanutti C., Vivenzio A., Di Giacomo S., Colombo C., Ferrazzoli I., Ricci G. (1995):
LDL-aferesi: indicazioni alle diverse metodiche.In SIdE. VII Congresso Nazionale. Napoli, 16-19 Maggio. Atti. Poligrafica F.lli Ariello, Ed. S.A.S., Napoli; pp. 54-66.

200 Stefanutti C., Vivenzio A., Di Giacomo S., Colombo C., Mazzarella B., Fontana M., Alessandri C., Ricci G. (1995):
Trattamento dell ascite refrattaria mediante ascitoaferesi. In SIdE. VII Congresso Nazionale. Napoli, 16-19 Maggio. Atti. Poligrafica F.lli Ariello, Ed. S.A.S., Napoli; pp. 244-252.

201 Stefanutti C., Vivenzio A., Di Giacomo S., Colombo C., Mazzarella B., Fontana M., Ricci G. (1996):
A new treatment of refractory ascites: ascitoapheresis.
Int. J. Artif. Organs, 11: 46-47. IF: 1.245

202 Stefanutti C., Mazzarella B., Di Giacomo S., Vivenzio A., (1996):
Profilo plasmatico della lipoproteina (a) in pazienti affetti da grave ipercolesterolemia familiare in trattamento mediante plasmaferesi terapeutica. In: Atti del IV Meeting di aggiornamento: Lipoproteina (a): nuovo fattore di rischio aterogeno. Siena, 22 Febbraio, pp. 61-68.

203 Stefanutti C, Di Giacomo S., Vivenzio A., Mazzarella B., Bosco G., Colloridi V. (1996):
Pediatric LDL-apheresis: clinical experience in Italy s largest sample. First International Congress of the Group for Prevention of Atherosclerosis in Childhood. Budapest (H), October 13-16. Abstract, p. 25.

204 Stefanutti C., Vivenzio A., DI Giacomo S., Mazzarella B., Ricci G. (1996):
Pediatric LDL-apheresis: Italy s largest clinical experience.
World Apheresis Association. 6th International Congress. Florence (I), November, 11-14. Abstract, p. 107.

205 Stefanutti C., Vivenzio A., Di Giacomo S., Mazzarella B., Urbinati G.C. (1996):
Plasmapheresis in the treatment of primary hyperlipoproteinemia with hyperchilomicronemia.
World Apheresis Association. 6th International Congress. Florence (I), November,11-14. Abstract, p. 115.

206 Bosco G., Ventriglia F., Stefanutti C., Borzaga U., Belardi C., Colloridi V. (1996):
L ipercolesterolemia familiare omozigote: efficacia della plasmaferesi nella prevenzione e possibile risoluzione delle alterazioni coronariche. Rivista Italiana di pediatria. The Italian Journal of Pediatrics, vol. 22, n. 5-2, 87. IF: 0.065

207 Perrone G., Stefanutti C., Galoppi P., Anelli G., Capri O., Lucani G.C., Vivenzio A., Mazzarella B., Zichella L. (1996):
Effect of oral and transdermal hormonal replacement therapy on lipid profile and Lp (a) level in menopausal women with hypercholesterolemia.
Int. J. Fertility Women s Med., 41 (6), pp. 509-515. IF: 0.831

208 Bianciardi G., Tanganelli P., De Santi M.M., Brogi M., Weber G., Stefanutti C., Mazzarella
B., Vivenzio A., Di Giacomo S., Alessandri C. (1996):
Morfometria ultrastrutturale di leucociti e piastrine in pazienti con ipercolesterolemia familiare in trattamento LDL-aferetico.
X Congresso Nazionale della Societa Italiana per Lo Studio
dell Arteriosclerosi. Roma, Italia, 2-3 Dicembre. Abstract.

209 Berni A., Stefanutti C., Abbolito S., Di Giacomo S., Di Luozzo M.,
Vivenzio A., Papalia U., Nigri A. (1997):
Progressione-regressione di lesioni coronariche in pazienti con ipercolesterolemia sottoposti a plasmaferesi.
Congresso Nazionale di Cardiologia - XXVIII dell Associazione Nazionale Medici Cardiologi Ospedalieri. Firenze, Italia, 1-4 Giugno. Abstract, C38, p. 12.

210 Stefanutti C., Di Giacomo S., Vivenzio A. (1997):
Confronto tra diverse tecniche di LDL-aferesi.
VII Congresso Nazionale della Societa Italiana di Emaferesi ed Autotrasfusione Trieste, Italia, 11-13 Giugno. Abstract, p. 23.

211 Stefanutti C., Di Giacomo S., Vivenzio A., Mazzarella B., Bosco
G., Colloridi V. (1997):
Pediatric LDL-apheresis: clinical experience in Italy s largest sample.
In: Current trends in the prevention of atherosclerosis in childhood 2. Ed.: T. Szamosi; Published by: Convention Budapest Ltd. pp. 38-41.

212 Stefanutti C., Di Giacomo S., Vivenzio A., Bosco G., Colloridi V.,
Bucci A. (1997):
Diet only and diet plus simvastatin in the treatment of Heterozygous familial hypercholesterolemia in childhood.
Atherosclerosis, 134 (1,2), 4. P.411, p. 383. IF: 4.140

213 Stefanutti C., Di Giacomo S., Vivenzio A., Bosco G., Colloridi V.,
S. Trizza, A. Berni, A. Nigri, N. Koga (1997):
LDL-apheresis in the treatment of familial hypercholesterolemia in childhood.
Atherosclerosis, 134 (1,2), 4.P.412, pp. 383-384. IF: 4.140

214 Stefanutti C., Vivenzio A., Di Giacomo S., Mazzarella B., Notarbartolo A., Bertolini
S., Colloridi V., Bosco G., Nigri A., A. Berni, (1997):
LDL-apheresis in a homozygous familial hypercholesterolemic child aged 4.5.
Art. Organs. 21(10): 1126-1237. IF:1.599

215 Bianciardi G., Stefanutti C., Carducci A., Mazzarella B., Di Giacomo S., Vivenzio A., Tanganelli P., Alessandri C., Weber G., Ricci G. (1997):
Platelet activation in hypercholesterolemic patients submitted to therapeutic plasmapheresis. An ultrastructural study.
Hematology. 2: 491-496. IF:1.386

216 Stefanutti C., Di Giacomo S., Vivenzio A. (1997):
Comparison between different techniques of LDL-apheresis.
Int. J. Art. Organs. 21(S-6): 66-71. IF: 1.065

217 Stefanutti C., Vivenzio A., Di Giacomo S., Mazzarella B. (1997):
Ascitoaferesi: un nuovo approccio nel trattamento dell ascite tesa . In: Progressi scientifici e tecnologici in Medicina Trasfusionale . Atti del corso residenziale organizzato dalla ESTM (European School of Transfusion Medicine). Roma, 20-23 novembre. pp. 351-362.

218 Stefanutti C., Vivenzio A., Di Giacomo S. (1997):
Lipid Clinic - La scheda: Laboratorio di Plasmaferesi Terapeutica dell Istituto di Terapia Medica Sistematica, Universita degli Studi di Roma La Sapienza - Policlinico Umberto I.
Arteriosclerosi News, anno IV, 3., Sett-Dic. 1997- ISSN 1123 - 1378.

219 Stefanutti C., Vivenzio A., Lucani G.C., Di Giacomo S, Lucani E. (1998):
Effect of L-carnitine on plasma lipoprotein fatty acids pattern in patients with primary hyperlipoproteinemia.
Clin. Ter. 149: 115-119. IF: 0.177

220 Stefanutti C., Di Giacomo S., Vivenzio A., P. Caprari, Modesti D., Tarsia A., Cantafora A., Masella R. (1998):
In vitro oxidation of LDL isolated from homozygous and double heterozygous patients with familial hypercholesterolemia treated by LDL-apheresis. 70th EAS Congress - European Atherosclerosis Society Geneva, Switzerland, 6-9 Settembre. Abstract, p. 42.

221 Stefanutti C., Di Giacomo S., Vivenzio A., Ricci G. (1998):
Effects of Atorvastatin on serum lipoprotein levels in homozygous FH patients treated by LDL-apheresis. 70th EAS Congress - European Atherosclerosis Society. Geneva, Switzerland, 6-9 Settembre. Abstract, p. 105.

222 Pedro E., Gaspar A., Avelar E., Verissimo E., Stefanutti C., Gaddi A., Fellin R., Real; T., Boquinhas J., Gomes S. (1998):
Homozygous Familial Hypercholesterolemia (FH) child treatment with LDL-apheresis. Portoguese experience. 70th EAS Congress - European Atherosclerosis Society. Geneva, Switzerland, 6-9 Settembre. Abstract, p. 82.

223 Masella R., Mosiello A., Vari R., Caprari P., Tarsia A., Di Giacomo S., Vivenzio A., Cantafora A., Stefanutti C.,(1998):
Ossidabilita in vitro delle LDL nella ipercolesterolemia familiare grave dopo LDL-aferesi.
30° Congresso Nazionale della Societa Italiana di Biochimica Clinica e Biologia molecolare clinica.Venezia, Italia, 6-9 Ottobre. Abstract, p. 300.

224 Stefanutti C., Lucani G.C., Vivenzio A., Di Giacomo S (1999):
Diet only and diet plus simvastatin in the treatment of heterozygous familial hypercholesterolemia in childhood.
Drugs Exptl. Clin. Res. XXV (1): 23-28. IF: 0.797

225 Stefanutti C., Lucani G.C., Vivenzio A., Di Giacomo S, Lucani E., Mazzarella B..(1998):
Pattern of red blood cells and platelets cholesterol and fatty acids in homozygous familial hypercholesterolemic patients treated with LDL-apheresis.
Clin. Ter. 149: 231-233. IF: 0.177

226 Stefanutti C Vivenzio A., Di Giacomo S (1999):
La LDL-aferesi:stato attuale.
ATEROSCLEROSI 99, Convegno Nazionale Interdisciplinare. Roma, Italia, 19-21 Maggio.
Abstract.

227 Rabbone I., Stefanutti C., Cerutti F., Sacchetti C., Benech P., Di Giacomo S., Vivenzio A., Bosco G., Colloridi V., (2000):
Treatment of familial hypercholesterolemia (FH) in childhood: from heterozygous to compound heterozygous and homozygous.
Milanopediatria 2000. Milano, Italia, 25-28 Maggio. Abstract, p. 223.

228 Rabbone I., Stefanutti C., Cerutti F., Sacchetti C., De Vito B., Di Giacomo S., Vivenzio A., Bosco G. Coloridi V., (2000):
Trattamento dell ipercolesterolemia familiare (FH) in età pediatrica: dagli eterozigoti agli omozigoti.
Congresso Italiano di Pediatria. Palermo, Italia, 30 Settembre 4 Ottobre.
Abstract, p. 87.

229 Bertolini S., Cantafora A., Averna M., Cortese C., Motti C., Martini S., Pes G., Postiglione A., Stefanutti C., Blotta I., Pisciotta L., Rolleri M., Langheim S., Ghisellini M., Rabbone I., Calandra S., (2000):
Clinical expression of familial hypercholesterolemia in clusters of mutations of the LDL receptor gene that cause a receptor-defective or receptor-negative phenotype. Arterioscler Thromb Vasc Biol. 20: e41-e52. IF: 5.153

230 Stefanutti., Vivenzio A., Lucani G., Di Giacomo S., (2001):
La LDL-Aferesi: stato attuale.
Clin Ter.;152: 65-69. IF: 0.343

231 Stefanutti C., Di Giacomo S., Vivenzio A., Isacchi GC., Masella R., Caprari P., Vari R., Tarzia A., Mosiello A., Cantafora A. (2001):
Acute and long-term effects of low-density lipoprotein (LDL)-apheresis on oxidative damage to LDL and reducing capacity of erythrocytes in patients with severe familial hypercholesterolaemia.
Clin Sci.;100 (2): 191-198. IF: 2.454

232 Stefanutti C., Di Giacomo S, Vivenzio A., Colloridi V., Bosco G., Berni A., Rabbone I., Cerutti F., Bertolini S. (2001):
LDL-apheresis in a patient aged 3.5 years.
Acta Paediatr.;90: 1-7. IF: 1.715
233 Stefanutti C, Di Giacomo S, Di Caro M, Vivenzio A, Musca A.(2001):
DALI low-density lipoprotein apheresis in homozygous and heterozygous familial hypercholesterolemic patients using low-dose citrate anticoagulation.
Ther Apher Dial.; 5(5):364-71. IF: 1

234 C. Stefanutti, A. Vivenzio, S. Di Giacomo, M. Mareri, F. De Lorenzo, Musca (2002):
Tavola Rotonda S.I.N. 2001. III Congresso Nazionale della Società Italiana di Nefrologia. Gruppo aferesi terapeutica. Roma 5-6 Ottobre 2001 Sincronizzazione della Terapia Aferetica con la Terapia Farmacologica.Trattamento delle Dislipidemie. In: L aferesi terapeutica. Nuove prospettive. Stefano Passalacqua e Giorgio Splendiani Editori (Editoriale BIOS), pp. 71-84.

235 Stefanutti C., Vivenzio A., Di Giocomo S., Isacchi G., Musca A., Di Caro M. (2001):
LDL-apheresis induced anti-oxidative modification of LDL. XIII Congress of the European Society for Haemapheresis.Riva del Garda-Trento, Italy, September 16-19, 2001. Abstract.

236 Stefanutti C., Di Giacomo S., Vivenzio A., Di Caro M., Pace A., Musca A. (2001):
A novel Dali Apheresis System using low-dose citrate anticoagulation. XIII Congress of the European Society for Haemapheresis. Riva del Garda-Trento, Italy, September 16-19, 2001. Abstract.

237 Stefanutti C., Di Giacomo S., Di Caro M., Vivenzio A., Musca A. (2001):
Immunoadsorpion apheresis: clinical evaluation of two systems.XIII Congress of the European Society for Haemapheresis.
Riva del Garda-Trento, Italy, September 16-19. Abstract.

238 Stefanutti C., Mareri M., De Lorenzo F., Musca A. (2002):
DALI + children and other sensitised patients.
1st International DALI User Meeting, Bad Homburg, Germany, June 9-11, 2002. Abstract.

239 Stefanutti C., Mareri M., De Lorenzo F., Musca A. (2002):
DALI Low Citrate Anticoagulation LDL-Apheresis in the treatment of pediatric patients with severe familial hypercholesterolaemia. 9th Congress of the World Apheresis Association. 9 th Congrès de la Société Française d Hemaphéresè,
Paris, France, September 6-10, 2002. Abstract.

240 Stefanutti C., Di Giacomo S., Mareri M., De Lorenzo F., D alessandri G., Angelico F., Bucci A., Musca A., Mammarella A., (2003):
Immunoadsorption apheresis (Selesorb ©) in the treatment of chronic hepatitis C virus (HCV)- related type 2 mixed cryglobulinemia.
Transfusion and Apheresis Science. 28:207-214, 2003. IF: 0.984

241 Stefanutti C., Bucci A., Di Giacomo S., Fraone N., Pace A., Mareri M., Mammarella A., Musca A. (2004):
Efficacy, safety, and tolerability of combined simvastatin-fenofibrate treatment in primary mixed hyperlipidemia.
Clinical Drug Investigation, 24(8):465-477. IF: 0.798

242 Stefanutti C., Lanti A., Di Giacomo S., Mareri M., De Lorenzo F., Landolfo A., Isacchi G. (2004):
Therapeutic apheresis in low weight patients: technical feasibility, tolerance, compliance, and risks.
Transfusion and Apheresis Science. 31(1):3-10. IF: 0.984

243 Bertolini S, Pisciotta L, Di Scala L, Langheim S, Bellocchio A, Masturzo P, Cantafora A, Martini S, Averna M, Pes G, Stefanutti C, Calandra S. (2004):
Genetic polymorphisms affecting the phenotypic expression of familial hypercholesterolemia.
Atherosclerosis; 174(1):57-65. IF: 4.140

244 Marson P., Zanchin G., Stefanutti C. (2004):
Una breve riflessione storica sulla teoria infiammatoria dell aterosclerosi. Reumatismo. 2004 Jul-Sep;56(3):215-9.

245 Stefanutti C., Vivenzio A., Di Giacomo S., Mareri M., Ceccarelli F.,Valesini G. (2005): Cyclophosphamide and Immunoadsorption Apheresis Treatment of Lupus Nephritis Nonresponsive to Drug Therapy Alone.
BioDrugs, 19(2):129-133. IF: 1.905
246 Stefanutti C., D Alessandri G., Mareri M., Mazzarella B. (2005):
Prospective of immunoadsorption apheresis (Selesorb®) in the treatment of chronic manifestations of autoimmune diseases.
5th World Congress of the International Society for Apheresis (I.S.F.A.), Rostock/Warnemuende (Germany), May 4 -7, 2005. Abstract.

247 E. Bravo, M, Napolitano, I. Lopez-Soldado, M. Valeri, K.M.Botham and C. Stefanutti (2006):
Hypercholesterolemia alters the response of the plasma lipid profile and inflammatory markers to supplementation of the diet with n-3 polyunsaturated fatty acids from fish oil.
European Journal of Clinical Investigation 2006; 36:788-795. IF: 2.530

248 Mazza F., Stefanutti C., Di Giacomo S., Vivenzio A., Fraone N., Mazzarella B. and Bucci A. (2008):
Effects of low dose rosuvastatin and atorvastatin over 48 weeks treatment in patients with primary hypercholesterolemia.
Am J Cardiovasc Drugs.;8(4):265-70. IF: 2.39

249 Stefanutti C, Mazza F, Riccieri V (2008): Expert Commentary
Therapeutic plasmapheresis in the treatment of complicated Systemic Lupus Erythematosus.
In: Progress in Systemic Lupus Eythematosus Research Editor: Thomas I. Seward pp. 1-8 Pub. Date: 2008 - 1st Quarter Pages: 260 pp. ISBN: 1-60021-861-x. Frank Columbus Ed. Nova Science Publishers, Inc. New York,

250 Stefanutti C, Di Giacomo S, Mazzarella B, Castelli A.( 2009):
LDL apheresis: a novel technique (LIPOCOLLECT 200).
Artif Organs. 2009 Dec;33(12):1103-8. IF:1.599

251 Stefanutti C, Vivenzio A, Di Giacomo S, Labbadia G, Mazza F,D'Alessandri G, Ferraro PM, Masala C. (2009):
Immunoadsorption apheresis and immunosuppressive drug therapy in the treatment of complicated HCV-related cryoglobulinemia.
J Clin Apher. 2009;24(6):241-6. IF: 1.245

252 Stefanutti C, Mazza F, Vivenzio A, Di Giacomo S, Perrone G, Serra M, Bucci A. (2009):
Combined treatment with Dif1stat and diet reduce plasma lipid indicators of moderate hypercholesterolemia more effectively than diet alone: a randomized trial in parallel groups.
Lipids. 2009 Dec;44(12):1141-8. IF: 1.919

253 Stefanutti C (2009):
Clinical trials in apheresis.
Ther Apher Dial. 2009 Jun;13(3):171-3. IF: 1.308

254 Stefanutti C, Vivenzio A, Di Giacomo S, Mazzarella B, Bosco G, Berni A (2009):
Aorta and coronary angiographic follow-up of children with severe hypercholesterolemia treated with low- density lipoprotein apheresis.
Transfusion. 2009 Jul;49(7):1461-70. IF: 3.300

255 De Silvestro G, Tison T, Vicarioto M, Bagatella P, Stefanutti C, Marson P. (2009):
The Italian Registry of Pediatric Therapeutic Apheresis: a report on activity during 2005.
J Clin Apher. 2009;24(1):1-5. IF: 1.245

256 Stefanutti C, D'Alessandri G, Russi G, De Silvestro G, Zenti MG, Marson P, Belotherkovsky D, Vivenzio A, Di Giacomo S.(2009):
Treatment of symptomatic HyperLp(a)lipoproteinemia with LDL-apheresis: a multicentre study.
Atheroscler Suppl. 2009 Dec 29;10(5):89-94. IF: 3.078

257 Stefanutti C, Di Giacomo S, Vivenzio A, Labbadia G, Mazza F, D'Alessandri G, Russi G, De Silvestro G, Marson P (2009):
Therapeutic plasma exchange in patients with severe hypertriglyceridemia: a multicenter study.
Artif Organs. 2009 Dec;33(12):1096-102. IF: IF:1.599

258 Stefanutti C; Italian Multicenter Study on Low-density Lipoprotein Apheresis Working Group. (2010):
Italian Multicenter Study on Low-Density Lipoprotein Apheresis: retrospective analysis (2007).
Ther Apher Dial. 2010 Feb;14(1):79-86. IF: 1.308

259 Pignatelli P, Carnevale R, Cangemi R, Loffredo L, Sanguigni V, Stefanutti C, Basili S, Violi F.(2010):
Atorvastatin inhibits gp91phox circulating levels in patients with hypercholesterolemia.
Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):360-7. Epub 2009 Dec 3. Erratum in: Arterioscler Thromb Vasc Biol. 2014 Sep; 34(9):e 20. IF: 6.875

260 Stefanutti C (2010):
The 2009 2nd Italian Consensus Conference on LDL-apheresis.
Nutr Metab Cardiovasc Dis. 2010 Dec; 20(10):761-2. IF: 3.805

261 II Consensus Conference Italiana sulla LDL-aferesi CORSO INTERDISCIPLINARE DI AGGIORNAMENTO LIPIDCLUB 2009 Roma, 15 Maggio 2009. Atti in Italiano pubblicati anche sui siti web delle seguenti Società Scientifiche e No Profit: SISA, SIdEM, SIN, SIMI, SMILDLa, ANIF.
In Inglese: Stefanutti C (2010):
The 2009 2nd Italian Consensus Conference on LDL-apheresis.
Nutrition, Metabolism & Cardiovascular Diseases. 20(10) 761-762.

262 Stefanutti C, Vivenzio A, Di Giacomo S, Mazzarella B, Ferraro PM, Abbolito S. (2010):
Treatment of symptomatic hyperLp(a)lipidemia with LDL-apheresis vs. usual care.
Transfus Apher Sci. 2010 Feb;42(1):21-6. IF: 1.587

263 Stefanutti C, Di Giacomo S, Labbadia G.(2011):
Timing clinical events in the treatment of pancreatitis and hypertriglyceridemia with therapeutic plasmapheresis.
Transfus Apher Sci. 2011 Aug;45(1):3-7. IF: 1.250

264 Zenti MG, Stefanutti C. (2011):
Effects of selective H.E.L.P. LDL-apheresis on plasma inflammatory markers concentration in severe dyslipidemia: Implication for anti-inflammatory response.
Cytokine. 2011 Dec;56(3):850-4. IF: 3.333

265 Stefanutti C, Morozzi C, Petta A. (2011):
Lipid and low-density-lipoprotein apheresis. Effects on plasma inflammatory profile and on cytokine pattern in patients with severe dyslipidemia.
Cytokine. 2011 Dec;56(3):842-9. IF: 3.333

266 Stefanutti C, Vivenzio A, Ferraro PM, Morozzi C, Belotherkovsky D. (2011):
Apheresis-inducible cytokine pattern change in severe, genetic dyslipidemias.
Cytokine. 2011 Dec;56(3):835-41. IF: 3.333

267 Stefanutti C and Morozzi C (2012):
Low density lipoprotein apheresis Chapter ID: _8305_Chapter Title: Low Density Lipoprotein apheresis. Book ID: _921_Book Title: Hemodialysis, When, How, Why.

268 Stefanutti C, Di Giacomo S, Morozzi C. (2012):
LDL apheresis: an update and overview. LDL apheresis in Sardinia, Italy (SMILDLa).
G Ital Nefrol. 2012 Jan-Feb;29 Suppl 54: S14-8. Italian.

269 Stefanutti C, Morozzi C, Perrone G, Di Giacomo S, Vivenzio A, D'Alessandri G. (2012):
The lipid- and lipoprotein- [LDL-Lp(a)] apheresis techniques. Updating.
G Chir. 2012 Nov-Dec;33(11-12):444-9. IF: 0.85

270 Bosi S, Barbieri A, Baldelli M, Censi S, Naldi M, Squeri A, Morozzi C, Stefanutti C. (2012):
How new imaging techniques can aid in defining the cardiovascular profile of the high-risk patient.
G Chir. 2012 Nov-Dec;33(11-12):429-34. IF: 0.85

271 Stefanutti C, Mazza F. (2012):
Multiple lipid-lowering treatment in pediatric patients with hyperlipidemia.
Med Chem. 2012 Nov;8(6):1171-81. IF: 2.577

272 Stefanutti C, Morozzi C, Di Giacomo S. (2012):
New clinical perspectives of hypolipidemic drug therapy in severe
hypercholesterolemia.
Curr Med Chem. 2012;19(28):4861-8. Review. IF: 4.738

273 Cuchel M, Meagher EA, du Toit Theron H, Blom DJ, Marais AD, Hegele RA, Averna MR, Sirtori CR, Shah PK, Gaudet D, Stefanutti C, Vigna GB, Du Plessis AM, Propert KJ,
Sasiela WJ, Bloedon LT, Rader DJ (2013):
Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study. Phase 3 HoFH Lomitapide Study investigators.
Lancet. 2013 Jan 5;381(9860):40-6. IF: 29.777

274 Stefanutti C, Julius U. (2013):
Lipoprotein apheresis: state of the art and novelties.
Atheroscler Suppl. 2013 Jan;14(1):19-27. IF: 3.078

275 Stefanutti C, Gozzer M, Pisciotta L, D'Eufemia P, Bosco G, Morozzi C, Papadia F, Shafii M, Di Giacomo S, Bertolini S. (2013):
A three month -old infant with severe hyperchylomicronemia: molecular diagnosis and extracorporeal treatment.
Atheroscler Suppl. 2013 Jan;14(1):73-6. IF: 3.078

276 Stefanutti C. (2013):
Treatment of severe genetic dyslipidemia: where are we going?
Ther Apher Dial. 2013 Apr;17(2):122-3. IF: 1.308

277 Stefanutti C, Labbadia G, Morozzi C. (2013):
Severe hypertriglyceridemia-related acute pancreatitis.
Ther Apher Dial. 2013 Apr;17(2):130-7. IF: 1.308

278 Stefanutti C, Morozzi C, Di Giacomo S; Italian Multicenter Study on Low-Density Lipoprotein Apheresis Working Group. (2013):
Italian multicenter study on low-density lipoprotein apheresis. Working Group 2009 survey.
Ther Apher Dial. 2013 Apr;17(2):169-78. IF: 1.308

279 Stefanutti C, Labbadia G, Morozzi C. (2013):
Severe hypertriglyceridemia-related acute pancreatitis: myth or reality?
Ther Apher Dial. 2013 Aug;17(4):464-5. IF: 1.308

280 Brunelli R, De Spirito M, Mei G, Papi M, Perrone G, Stefanutti C, Parasassi T. (2014):
Misfolding of apoprotein B-100, LDL aggregation and 17- - estradiol in atherogenesis.
Curr Med Chem. 2014;21(20):2276-83. Review. IF: 4.738

281 Stefanutti C, Labbadia G, Athyros VG. (2014):
Hypertriglyceridaemia, postprandial lipaemia and non-HDL cholesterol.
Curr Pharm Des. 2014;20(40):6238-48. Review. IF: 3.810

282 Stefanutti C, Thompson GR. (2015):
Lipoprotein apheresis in the management of familial hypercholesterolaemia: historical perspective and recent advances.
Curr Atheroscler Rep. 2015 Jan;17(1):465. IF: 3.417

283 Bianciardi G, Stefanutti C, Tanganelli I. (2015):
Platelet entropy is increased in familial hypercholesterolemia and in type 2 diabetic patients.
Int Angiol. 2015 Oct;34(5):489-94. Epub 2015 Feb 11. IF: 1.070

284 Bianciardi G, Aglianò M, Volpi N, Stefanutti C. (2015):
Geometric complexity identifies platelet activation in familial hypercholesterolemic patients.
Microsc Res Tech. 2015 Jun;78(6):519-22. IF: 1.300

285 Page MM, Stefanutti C, Sniderman A, Watts GF. (2015):
Recent advances in the understanding and care of familial hypercholesterolaemia: significance of the biology and therapeutic regulation of proprotein convertase subtilisin/kexin type 9.
Clin Sci (Lond). 2015 Jul;129(1):63-79. IF: 5.647

286 Stefanutti C, Blom DJ, Averna MR, Meagher EA, Theron Hd, Marais AD, Hegele RA, Sirtori CR, Shah PK, Gaudet D, Vigna GB, Sachais BS, Di Giacomo S, du Plessis AM, Bloedon LT, Balser J, Rader DJ, Cuchel M; Phase 3 HoFH Lomitapide Study Investigators. (2015):
The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia - a post-hoc analysis of a Phase 3, single-arm, open-label trial.
Atherosclerosis. 2015 Jun;240(2):408-14. IF: 4.421

287 Stefanutti C, Julius U. (2015)
Treatment of primary hypertriglyceridemia states--General approach and the role of extracorporeal methods.
Atheroscler Suppl. 2015 May; 18:85-94. IF: 3.60

288 Stefanutti C, D'Alessandri G, Petta A, Harada-Shiba M, Julius U, Soran H, Moriarty PM, Romeo S, Drogari E, Jaeger BR; Mighty Medic (Multidisciplinary International Group for Hemapheresis Therapy and Metabolic DIsturbances Contrast) Working Group. (2015):
First on-line survey of an international multidisciplinary working group (MightyMedic) on current practice in diagnosis, therapy and follow-up of dyslipidemias.
Atheroscler Suppl. 2015 May; 18:241-50. IF: 3.60

289 Sjouke B, Hovingh GK, Kastelein JJ, Stefanutti C. (2015):
Homozygous autosomal dominant hypercholesterolaemia: prevalence, diagnosis, and current and future treatment perspectives.
Curr Opin Lipidol. 2015 Jun;26(3):200-9. IF: 5.336

290 Hovingh GK, Smits LP, Stefanutti C, Soran H, Kwok S, de Graaf J, Gaudet D, Keyserling CH, Klepp H, Frick J, Paolini JF, Dasseux JL, Kastelein JJ, Stroes ES. (2015):
The effect of an apolipoprotein A-I-containing high-density lipoprotein-mimetic particle (CER-001) on carotid artery wall thickness in patients with homozygous familial hypercholesterolemia: The Modifying Orphan Disease Evaluation (MODE) study.
Am Heart J. 2015 May;169(5):736-742.e1. IF: 4.332

291 Braamskamp MJ, Stefanutti C, Langslet G, Drogari E, Wiegman A, Hounslow N, Kastelein JJ; PASCAL Study Group. (2015):
Efficacy and safety of pitavastatin in children and adolescents at high future cardiovascular risk.
J Pediatr. 2015 Aug;167(2):338-43.e5. IF: 3.890

292 Dadkhah M, Stefanutti C. (2015):
Hijacked journals are emerging as a challenge for scholarly publishing.
Pol Arch Med Wewn. 2015;125(10):783-4. IF: 2.070

293 Sijbrands EJ, Nieman K, Budoff MJ; FH CTA Consortium. (2015):
Cardiac computed tomography imaging in familial hypercholesterolaemia: implications for therapy and clinical trials.
Curr Opin Lipidol. 2015 Dec;26(6):586-92. IF: 5.336

294 Averna M, Cefalù AB, Stefanutti C, Di Giacomo S, Sirtori CR, Vigna G. (2016):
Individual analysis of patients with HoFH participating in a phase 3 trial with lomitapide: The Italian cohort.
Nutr Metab Cardiovasc Dis. 2016 Jan;26(1):36-44. IF: 4.174

295 Sahebkar A, Simental-Mendía LE, Stefanutti C, Pirro M. (2016):
Supplementation with coenzyme Q10 reduces plasma lipoprotein(a) concentrations but no other lipid indices: a systematic review and meta-analysis.
Pharmacol Res. 2016 Mar; 105:198-209. IF: 2.037

296 Stefanutti C, Mazza F, Steiner M, Watts GF, De Nève J, Pasqualetti D, Paal J. (2016):
Relationship between Sustained Reductions in Plasma Lipid and Lipoprotein Concentrations with Apheresis and Plasma Levels and mRNA Expression of PTX3 and Plasma Levels of hsCRP in Patients with HyperLp(a)lipoproteinemia.
Mediators Inflamm. 2016;2016:4739512. IF: 3.232

297 Dadkhah M, Stefanutti C, Bianciardi G. (2016):
Scientific information security in information science and academic publishing.
Artif Organs. 2016 May;40(5):425-30. IF: 0.803

298 Stefanutti C, Morozzi C, Di Giacomo S, Sovrano B, Mesce D, Grossi A. (2016):
Management of homozygous familial hypercholesterolemia in real-world clinical practice: A report of 7 Italian patients treated in Rome with lomitapide and lipoprotein apheresis.
J Clin Lipidol. 2016 Jul-Aug;10(4):782-789. IF: 5.891

299 Stefanutti C, Morozzi C. (2016):
HyperLp(a)lipoproteinaemia: unmet need of diagnosis and treatment?
Blood Transfus. 2016 Sep;14(5):408-12. IF: 1.93

300 Ogura M, Makino H, Kamiya C, Yoshimatsu J, Soran H, Eatough R, Perrone G, Harada-Shiba M, Stefanutti C. (2016):
Lipoprotein apheresis is essential for managing pregnancies in patients with homozygous familial hypercholesterolemia: Seven case series and discussion.
Atherosclerosis. 2016 Nov;254:179-183. IF: 4.239

301 Perrone G, Brunelli R, Marcoccia E, Zannini I, Candelieri M, Gozzer M, Stefanutti C. (2016):
Therapeutic Apheresis in Pregnancy: Three Differential Indications with Positive Maternal and Fetal Outcome.
Ther Apher Dial. 2016 Dec;20(6):677-685. IF:1.529

302 Watts GF, Stefanutti C. (2016):
ODYSSEY ESCAPE: is PCSK9 inhibition the Trojan Horse for the use of lipoprotein apheresis in familial hypercholesterolaemia?
Eur Heart J. 2016 Dec 21;37(48):3596-3599. IF: 20.212

303 Stefanutti C. (2017):
The 1st and the 2nd Italian Consensus Conferences on low-density lipoprotein-apheresis. A practical synopsis and update.
Blood Transfus. 2017 Jan;15(1):42-48. IF: 2.138

304 Stefanutti C, Julius U, Watts GF, Harada-Shiba M, Cossu M, Schettler VJ, De Silvestro G, Soran H, Van Lennep JR, Pisciotta L, Klör HU, Widhalm K, Moriarty PM; MIGHTY MEDIC Multinational Society. (2017):
Toward an international consensus-Integrating lipoprotein apheresis and new lipid-lowering drugs.
J Clin Lipidol. 2017 Jul - Aug;11(4):858-871.e3. IF: 3.580

305 Blom DJ, Averna MR, Meagher EA, du Toit Theron H, Sirtori CR, Hegele RA, Shah PK, Gaudet D, Stefanutti C, Vigna GB, Larrey D, Bloedon LT, Foulds P, Rader DJ, Cuchel M. (2017):
Long-term efficacy and safety of the microsomal triglyceride transfer protein inhibitor lomitapide in patients with homozygous familial hypercholesterolemia.
Circulation. 2017 Jul 18;136(3):332-335. IF: 15.211

306 Stefanutti C, Mazza F, Pasqualetti D, Di Giacomo S, Watts GF, Massari MS, de Neve J, Morozzi C, Fischer M. (2017):
Lipoprotein apheresis downregulates IL-1 , IL-6 and TNF- mRNA expression in severe dyslipidaemia.
Atheroscler Suppl.; 30:200-208. IF: 3.423

307 Stefanutti C, Mazza F, Mesce D, Morozzi C, Di Giacomo S, Vitale M, Pergolini M. (2017):
Monascus purpureus for statin and ezetimibe intolerant heterozygous familial hypercholesterolaemia patients: A clinical study.
Atheroscler Suppl. 2017 Nov; 30:86-91. doi: 10.1016/j.atherosclerosissup.2017.05.021
IF: 3.423

Stefanutti C, Mazza F, Mesce D, Morozzi C, Di Giacomo S, Vitale M, Pergolini M. (2017):
Corrigendum to Monascus purpureus for statin and ezetimibe intolerant heterozygous familial hypercholesterolaemia patients: A clinical study
Atheroscler Suppl. 2017 Nov 16. pii: S1567-5688(17)30145-9.

308 Defesche JC, Stefanutti C, Langslet G, Hopkins PN, Seiz W, Baccara-Dinet MT, Hamon SC, Banerjee P, Kastelein JJP. (2017):
Efficacy of alirocumab in 1191 patients with a wide spectrum of mutations in genes causative for familial hypercholesterolemia.
J Clin Lipidol. 2017 Nov - Dec;11(6):1338-1346.e7. IF: 3.580

Corrigendum to "Efficacy of alirocumab in 1191 patients with a wide spectrum of mutations in genes causative for familial hypercholesterolemia" J Clin Lipidol 11 (2017) 1338-1346. Defesche JC, Stefanutti C, Langslet G, Hopkins PN, Seiz W, Baccara-Dinet MT, Hamon SC, Banerjee P, Kastelein JJP. J Clin Lipidol. 2020 Sep-Oct;14(5):742. doi: 10.1016/j.jacl.2020.09.010. PMID: 33138962

309 Hovingh GK, Raal FJ, Dent R, Stefanutti C, Descamps O, Masana L, Lira A, Bridges I, Coll B, Sullivan D. (2017):
Long-term safety, tolerability, and efficacy of evolocumab in patients with heterozygous familial hypercholesterolemia.
J Clin Lipidol. 2017 Nov - Dec;11(6):1448-1457. IF: 3.580

310 Adam, S., Mohammad, J.B., Ho, J.H., Schofield, J.D., Kwok, S., Siahmansur, T., Liu, Y., Syed, A.A., Dhage, S.S., Stefanutti, C., Donn, R., Malik, R.A., Banach, M., Durrington, P.N., Soran, H. (2018):
Hypercholesterolaemia - practical information for non- specialists.
Arch Med Sci. 2018 Jan;14(1):1-21. IF: 2.340

311 Hartgers ML, Defesche JC, Langslet G, Hopkins PN, Kastelein JJP, Baccara-Dinet MT, Seiz W, Hamon S, Banerjee P, Stefanutti C. (2018):
Alirocumab efficacy in patients with double heterozygous, compound heterozygous, or homozygous familial hypercholesterolemia.
J Clin Lipidol. 2018 Mar - Apr;12(2):390-396.e8. IF: 3.860

312 Zenti MG, Stefanutti C, Sanga V, Altomari A, Fabris A, Dauriz M, Bonora E. (2018):
Evolocumab and lipoprotein apheresis combination therapy may have synergic effects to reduce low-density lipoprotein cholesterol levels in heterozygous familial hypercholesterolemia: A case- report.
J Clin Apher. 2018 Aug;33(4):546-550. IF: 1.629

313 Moulin P, Dufour R, Averna M, Arca M, Cefalù AB, Noto D, D'Erasmo L, Di Costanzo A, Marçais C, Alvarez-Sala Walther LA, Banach M, Borén J, Cramb R, Gouni-Berthold I, Hughes E, Johnson C, Pintó X, Reiner , van Lennep JR, Soran H, Stefanutti C, Stroes E, Bruckert E. (2018):
Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an "FCS score".
Atherosclerosis. 2018 Aug; 275:265-272. IF: 3.919

314 Stefanutti C, Zenti MG. (2018):
Lipoprotein Apheresis and PCSK9-Inhibitors. Impact on Atherogenic Lipoproteins and Anti-Inflammatory Mediators in Familial Hypercholesterolaemia.
Curr Pharm Des. 2018;24(31):3634-3637. IF: 2.208

315 Moulin, P., Dufour, R., Averna, M., Arca, M., Cefalù, A.B., Noto, D., D'Erasmo, L., Di Costanzo, A., Marçais, C., Walther, L.A.A.-S., Banach, M., Borén, J., Cramb, R., Gouni-Berthold, I., Hughes, E., Johnson, C., Pintó, X., Reiner, Z., van Lennep, J.R., Soran, H., Stefanutti, C., Stroes, E., Bruckert, E. (2018):
Characterisation of patients with familial chylomicronaemia syndrome (FCS) and multifactorial chylomicronaemia syndrome (MCS): Establishment of an FCS clinical diagnostic score.
Atherosclerosis 2018 Aug; 275:265-272. Data in Brief, 21, pp. 1334-1336. (2019) DOI: 10.1016/j.dib.2018.10.125. IF: 3.919

316 Stefanutti C, Pang J, Di Giacomo S, Wu X, Wang X, Morozzi C, Watts GF, Lin J. (2019):
A cross-national investigation of cardiovascular survival in homozygous familial hypercholesterolemia: The Sino-Roman Study. J Clin Lipidol. 2019;S1933-2874(19)30177-1. IF: 3.860

317 Stulnig TM, Morozzi C, Reindl-Schwaighofer R, Stefanutti C. (2019):
Looking at Lp(a) and Related Cardiovascular Risk: from Scientific Evidence and Clinical Practice.
Curr Atheroscler Rep. 2019; 27;21(10):37. IF: 4.608

318 Perrone S, Perrone G, Brunelli R, Di Giacomo S, Galoppi P, Flammini G, Morozzi C, Stefanutti C. (2019):
A complicated pregnancy in homozygous familial hypercholesterolaemia treated with lipoprotein apheresis: A case report.
Atheroscler Suppl. 2019; 40:113-116. doi: 10.1016/j.atherosclerosissup.2019.08.033. Epub 2019 Aug 17. IF: 3.968

319 Perrone S, Brunelli R, Perrone G, Zannini I, Galoppi P, Di Giacomo S, Morozzi
C, Pisciotta L, Stefanutti C. (2019):
A successful term pregnancy with severe hypertriglyceridaemia and acute pancreatitis. Clinical management and review of the literature.
Atheroscler Suppl. 2019; 40:117-121. doi10.1016/j.atherosclerosissup.2019.08.032. Epub 2019 Aug 17. IF: 3.968

320 Bjelakovic B, Stefanutti C, Pisciotta L, Watts G, Bejiqi R. (2019):
Homozygous familial hypercholesterolaemia in childhood - The first case report in Southeast Europe.
Atheroscler Suppl. 2019; 40:122-124. doi: 10.1016/j.atherosclerosissup.2019.08.034. Epub Aug 17. IF: 3.968

321 Iqbal Z, Dhage S, Mohamad JB, Abdel-Razik A, Donn R, Malik R, Ho JH, Liu Y, Adam S, Isa B, Stefanutti C, Soran H. (2019):
Efficacy and safety of PCSK9 monoclonal antibodies.
Expert Opin Drug Saf. 2019;18(12):1191-1201. doi: 10.1080/14740338.2019.1681395. IF: 3.383

322 Stefanutti C, Mesce D, Pacella F, Di Giacomo S, Turchetti P, Forastiere M, Trovato Battagliola E, La Torre G, Smaldone G, Pacella E. (2019):
Optical coherence tomography of retinal and choroidal layers in patients with familial hypercholesterolaemia treated with lipoprotein apheresis.
Atheroscler Suppl. 2019; 40:49-54. doi: 10.1016/j.atherosclerosissup.2019.08.031.
IF: 3.968

323 Bjelakovic B, Stefanutti C, Bonic D, Vukovic V, Kavaric N, Saranac L, Kocic G, Klisic A, Jevtovi Stojmenov T, Lukic S, Jovic M, Bjelakovic M. (2019):
Serum uric acid and left ventricular geometry pattern in obese children.
Atheroscler Suppl. 2019; 40:88-93. doi: 10.1016/j.atherosclerosissup.2019.08.035.
IF: 3.968

324 Representatives of the Global Familial Hypercholesterolemia Community, Wilemon KA, Patel J, Aguilar-Salinas C, Ahmed CD, Alkhnifsawi M, Almahmeed W, Alonso R, Al-Rasadi K, Badimon L, Bernal LM, Bogsrud MP, Braun LT, Brunham L, Catapano AL, Cillíková K, Corral P, Cuevas R, Defesche JC, Descamps OS, de Ferranti S, Eiselé JL, Elikir G, Folco E, Freiberger T, Fuggetta F, Gaspar IM, Gesztes ÁG, Gro elj U, Hamilton-Craig I, Hanauer-Mader G, Harada-Shiba M, Hastings G, Hovingh GK, Izar MC, Jamison A, Karlsson GN, Kayikçioglu M, Koob S, Koseki M, Lane S, Lima-Martinez MM, López G, Martinez TL, Marais D, Marion L, Mata P, Maurina I, Maxwell D, Mehta R, Mensah GA, Miserez AR, Neely D, Nicholls SJ, Nohara A, Nordestgaard BG, Ose L, Pallidis A, Pang J, Payne J, Peterson AL, Popescu MP, Puri R, Ray KK, Reda A, Sampietro T, Santos RD, Schalkers I, Schreier L, Shapiro MD, Sijbrands E, Soffer D, Stefanutti C, Stoll M, Sy RG, Tamayo ML, Tilney MK, Tokgözoglu L, Tomlinson B, Vallejo-Vaz AJ, Vazquez-
Cárdenas A, de Luca PV, Wald DS, Watts GF, Wenger NK, Wolf M, Wood D, Zegerius A, Gaziano TA, Gidding SS. (2020)
Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action.
JAMA Cardiol. 2020;5(2):217-229. doi: 10.1001/jamacardio.2019.5173. IF: 8.610

325 Katsiki N, Mikhailidis DP, Bajraktari G, Miserez AR, Cicero AFG, Bruckert E,
Serban MC, Mirrakhimov E, Alnouri F, Reiner , Paragh G, Sahebkar A, Banach M;
International Lipid Expert Panel (ILEP). (2020):
Statin therapy in athletes and patients performing regular intense exercise - Position paper from the International Lipid Expert Panel (ILEP).
Pharmacol Res. 2020; 155:104719. doi: 10.1016/j.phrs.2020.104719. Epub 2020 Feb 19. IF: 5.780

326 Bjelakovic B, Stefanutti C, Vukovic V, Kavaric N, Saranac L, Klisic A, Lukic S,
Stankovic S, Jovic M, Prijic S, Bjelakovic M, Banach M. (2020):
Lipid profile and left ventricular geometry pattern in obese children.
Lipids Health Dis. 2020;19(1):109. doi: 10.1186/s12944-020-01285-9. IF: 2.906

327 Zhubi-Bakija F, Bajraktari G, Bytyçi I, Mikhailidis DP, Henein MY, Latkovskis G, Rexhaj Z, Zhubi E, Banach M; International Lipid Expert Panel (ILEP). (2020):
The impact of type of dietary protein, animal versus vegetable, in modifying cardiometabolic risk factors: A position paper from the International Lipid Expert Panel (ILEP).
Clin Nutr. 2020; S0261-5614(20)30251-X. doi: 10.1016/j.clnu.2020.05.017.
IF: 6.360
328 Stefanutti C. (2020):
Lomitapide-a Microsomal Triglyceride Transfer Protein Inhibitor for Homozygous Familial Hypercholesterolemia.
Curr Atheroscler Rep. 2020;22(8):38. doi: 10.1007/s11883-020-00858-4.
IF: 4.608

Correction to: Lomitapide - a Microsomal Triglyceride Transfer Protein Inhibitor for Homozygous Familial Hypercholesterolemia.
Stefanutti C. Curr Atheroscler Rep. 2020 Jul 15;22(8):41.
doi: 10.1007/s11883-020-00869-1.

329 Stefanutti C, Pisciotta L, Favari E, Di Giacomo S, Vacondio F, Zenti MG, Morozzi C, Berretti D, Mesce D, Vitale M, Pasta A, Ronca A, Garuti A, Manfredini M, Anglés-Cano E, Marcovina SM, Watts GF; Multidisciplinary International Group for Hemapheresis TherapY and MEtabolic DIsorders Control MIGHTY MEDIC.ORG (2020):
Lipoprotein(a) concentration, genetic variants, apo(a) isoform size, and cellular cholesterol efflux in patients with elevated Lp(a) and coronary heart disease submitted or not to lipoprotein apheresis: An Italian case-control multicenter study on Lp(a).
J Clin Lipidol. 2020;14(4):487-497.e1. doi: 10.1016/j.jacl.2020.05.002. IF: 3.860

330 Santos, R.D., Ruzza, A., Hovingh, G.K., Wiegman, A., Mach, F., Kurtz, C.E., Hamer, A., Bridges, I., Bartuli, A., Bergeron, J., Szamosi, T., Santra, S., Stefanutti, C., Descamps, O.S., Greber-Platzer, S., Luirink, I., Kastelein, J.J.P., Gaudet, D. (2020):
Evolocumab in pediatric heterozygous familial hypercholesterolemia.
New England Journal of Medicine, 2020; 383 (14), pp. 1317-1327. IF: 74.699

331 Efficacy and Safety of PCSK9 Monoclonal Antibodies in Patients With Diabetes
Marouf, B.H., Iqbal, Z., Mohamad, J.B., ...Stefanutti, C., Soran, H.
Clinical Therapeutics, 2022, 44(2), pp. 331 348 IF: 3.765

332 Risk assessment and clinical management of children and adolescents with heterozygous familial hypercholesterolaemia. A position paper of the associations of preventive pediatrics of Serbia, mighty medic and international lipid expert panel
Bjelakovic, B., Stefanutti, C., Reiner, ., ...Harada-Shiba, M., Banach, M.
Journal of Clinical Medicine, 2021, 10(21), 4930 IF: 5.583

333 Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases A position paper from the International Lipid Expert Panel (ILEP). Ruscica, M., Penson, P.E., Ferri, N., ...Zhisheng, J., Zirlik, A.
Progress in Cardiovascular Diseases, 2021, 67, pp. 40 52
IF: 6.763
334 Current Approach to the Diagnosis and Treatment of Heterozygote and Homozygous FH Children and Adolescents
Cohen, H., Stefanutti, C., Di Giacomo, S., ...Martino, F., Bosco, G.
Current Atherosclerosis Reports, 2021, 23(6), 30 IF: 4.32

335 The impact of type of dietary protein, animal versus vegetable, in modifying cardiometabolic risk factors: A position paper from the International Lipid Expert Panel (ILEP)
Zhubi-Bakija, F., Bajraktari, G., Bytyçi, I., ...Zhisheng, J., Zirlik, A.
Clinical Nutrition, 2021, 40(1), pp. 255 276 IF:6.402

Luogo e data: Roma, 23 Maggio 2022 Claudia Stefanutti